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ACCURATE METHODOLOGY FOR MONITORING BIOMEMBRANE EVENTS
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A Dissertation submitted in partial fulfillment of the requirements for the degree of Doctorate of
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Virginia Commonwealth University, 2012

Major Director: Dr. Vladimir A. Sidorov
ASSOCIATE PROFESSOR, DEPARTMENT OF CHEMISTRY

This study describes the synthesis and characterization of a new receptor (cyclen 1)
capable of strong selective binding of pyrene-based anionic dyes under near-physiological
conditions. This receptor comprises four naphthylthiourea groups tethered to a cyclen core via
an ester linkage. The most important finding was the ability of cyclen 1 to bind efficiently to a
pH-sensitive pyranine dye, a dye that is commonly used in various biomembrane assays. The
high affinity of cyclen 1 to pyranine, its impermeability to the lipid bilayer membrane, fast
kinetics of binding, and ability to quench pyranine’s fluorescence were used as a basis for a new
membrane leakage assay. This membrane leakage assay is fully compatible with the commonly

xxiv
applied pH-stat transport assay, and therefore it allows for differentiation of ion transport and
nonselective leakage mechanisms within a single set of experiments.
In the second part of this study a new methodology for the detection of lipid flip was
developed. This methodology relies on the quenching of the fluorescence of a newly synthesized
cascade-blue-labeled lipid through complex formation with cyclen 1.

This receptor-dye

complexation also has high affinity for binding at micromolar concentrations and can be reversed
by either competitive displacement of the lipid probe or by enzymatic degradation of the receptor
leading to the label release and fluorescence dequenching. This new methodology is suitable for
the study of lipid flip in both model spherical bilayer membranes and in-vitro experiments, and is
less invasive to the model and cell membranes than the commonly utilized 7-nitro-1,2,3benzoxadiazol-4-yl (NBD)-dithionite methodology.
Lastly, new pH-sensitive lipids were synthesized and utilized in the formulation of
liposomes suitable for controlled drug release. These liposomes contain various amounts of
internal NaCl and undergo internal acidification upon the exogenous addition of an HCl cotransporter in a physiologically relevant NaCl solution. Therefore, acidification ultimately leads
to the hydrolysis of the pH-sensitive lipids and subsequent contents release. These liposomes
were found to be insensitive to physiological concentrations of human serum albumin and to be
non-toxic to cells at concentrations exceeding pharmacological relevance. These results render
this new drug release model potentially suitable for in vivo applications.

Chapter 1
Introduction
1.1 Introduction to Biomembranes
Biological membranes are one of the smallest and yet most complex building blocks in
human organisms and the very basis of life as we know it.1 These membranes provide a
structural barrier that separates the intracellular components from their extracellular
surroundings. The selectively permeable cell walls are comprised of amphiphilic lipid molecules
that contain a polar head group and a nonpolar hydrophobic tail. These lipids comprise the
structural component of the phospholipid bilayer (Figure 1.1). Embedded within the lipid
bilayer are functional components consisting of specialized proteins that are capable of a vast
range of cellular processes, including cell
signaling for cell adhesion, cell division,
and transport of nutrients.2 These highly

Amphiphilic Lipid
Molecule
Polar Head
Apolar Tail

specialized proteins enable and control the
selective diffusion of biomolecules and ions
(including food intake and waste excretion),
which is critical for cell survival.3 Cells
control

these

movements

through

transmembrane protein complexes, which

Figure 1.1: Simplified Depiction of Bilayer
Membrane

can form gated pores (discussed in detail in Section 1.3.1).4 Additionally there are multiple
enzymes within these membranes such as flippases, floppases and scramblases which are
responsible for cell signaling and membrane asymmetry (discussed in Section 1.3.3).5
Further elucidation and understanding of the mechanisms for these protein activities have
become a primary goal of many research groups. As a result of this research, the way that
scientists perceive and view the cellular membrane is constantly evolving.6 Even over the last
two decades cellular information has dramatically changed due to the newly recognized capacity
for biomembranes to partition and form transient domains.6

Research has shown that

biomembranes are naturally asymmetric in their shape and lipid composition,7 and that within
cells there are aggregates of specific proteins that are responsible for critical cellular processes
and functions. Some of these functions include cell formation and division, apoptosis,8 transport,
cell trafficking,9 and endocytosis,10 all of which are briefly discussed in Section 1.2. All of these
cellular activities are of particular interest because of their direct involvement in several disease
processes, known as channelopathies, which are discussed in Section 1.3.2.
The vast complexity of biomembranes and their respective cellular functions have
necessitated the analysis of secondary complexes and subsystems within biological membranes.
This breakdown of the cell into smaller, simpler entities for study, has led to membrane models
and mechanistically specific assays. The development of several model cellular systems, such as
patch clamp and planar lipid bilayer systems (Section 1.5)11 have enabled scientists to gain
invaluable insight into the mechanism of critical biomembrane processes. In order to determine
more information about complicated cellular functions, researchers have utilized liposomes,
which are extremely simplified cell models (Section 1.4).12 Within these liposomal systems
2

scientists can control a variety of factors including size, lipid and protein composition, and intraand extracellular composition.

However, even within these model systems, the ability to

accurately monitor cellular activities and functions as well as to decipher the mechanisms
through which they take place remains as a challenging undertaking.
1.2 Introduction to Highly Specific Membrane Functions
The strict regulation of cellular processes is vital for cell survival, including the formation
of new cells through cell division (mitosis and cytokinesis), fusion of cells, endocytic uptake and
exocytic release of molecular compounds, and apoptosis.

Within all of these processes,

biomembrane activity plays a central role. Although there are a multitude of cellular functions,
only the ones that are relevant to the present studies will be introduced.
1.2.1 Biomembrane Rafts and Caveola Domains
As depicted in Figure 1.1, cells consist of a bilayer membrane that contains an inner and
outer ‘leaflet’ as well as an internal aqueous compartment.

These bilayer membranes are

composed of multiple lipids and membrane bound proteins, which are not symmetrically
distributed throughout the bilayer membrane.

The primary components that comprise this

bilayer membrane include glycosphinogolipids, sphinogolipids, and cholesterol.13 Research has
led to the discovery of aggregates of particular lipids and proteins to form transient “domains” or
“lipid rafts”6, 10 within these bilayers, which have been associated with multiple cell trafficking
and signaling pathways.10, 13 This area is still highly debated, although it is generally accepted
that these small microdomains persist between nanoseconds to minutes depending on their size
and function.13

3

Recently, much research has been devoted to the study of caveolae14 (a subset of lipid
rafts) for their role in molecular transport, internalization and endocytic pathways, and signal
transduction.10 First presented by Palade and Yamada in the 1950’s, caveolae are known for
their flask-like invaginations, which are capable of acting as vesicle transporters.15

Both

caveolae and lipid rafts are often analyzed after isolation by either detergent-based or nondetergent based methods;13 however, it is arguable that after these microdomains have been
removed, they are no longer representative of intact cellular rafts.10 Therefore, the need for in
situ lipid probes is paramount in order to accurately define these domains.16, 17 Currently, the
most common methods for detecting and studying lipid domains are atomic force microscopy
(AFM)17-20 and fluorescent probes.16, 21-23
1.2.2 Endocytosis and Exocytosis
In the most general sense, endocytosis refers to the ability of a cell to uptake molecular
components (proteins, lipids, drugs etc.) through encapsulation within an endovesicle in the
cell.24 The term ‘endovesiculation’ refers to the same process but within vesicles or model
membranes instead of live cells.25 Endocytosis is important due to its association with lipid and
protein trafficking.26-28 Although the most common type of endocytosis is clathrin-mediated,
recent work has led to the discovery of ‘clathrin-independent pathways’.29, 30 Even though the
exact mechanisms and function of caveolae are not fully understood, it is known that they
participate in endocytosis31 as well as transcytosis (transport across cell layer) of important
proteins across the endothelial barrier.32 Whereas endocytosis refers to the uptake of molecular
components, exocytosis refers to the excretion or efflux of molecular compounds as well as
unwanted debris.33-35 During caveolar exocytosis a complex protein mechanism leads to the
4

fusion of an intracellular vesicle with the cytosolic side of the biomembrane and the eventual
release of vesicle contents to the extracellular surroundings.36,

37

Current methodologies for

monitoring exocytosis include patch clamp, fluorometry and ultramicroelectrode electrochemical
techniques.37 Recent review articles give detailed descriptions of both the intracellular as well as
the intercellular models for signaling by caveolae38 and their monitoring by fluorescence.39, 40
1.2.3 Apoptosis
Apoptosis, or programmed cell death, is an extremely important, highly regulated and
complicated process that is necessary for the control and removal of damaged or surplus cells.41
By definition this genetic process is “characterized morphologically by membrane blebbing,
chromatin condensation, loss of cell volume and DNA fragmentation, and biochemically by
caspase activation.”42 It has been found that suppression, overexpression, and mutation of the
genes that trigger and coordinate the apoptotic cascade are associated with several disease
processes, including inflammation, cancer, autoimmune disorders, Alzheimer’s and Parkinson’s
disease to name just a few.41,

43

Therefore, there is a strong desire among the scientific and

medical community to determine not only the mechanisms by which these processes occur but
also how to correct this mechanistic malfunction. Apoptosis is also commonly studied by
Western blotting, cytometry, and fluorescence spectroscopy.44-49
1.3 Mechanisms and Implications of Molecular Ion Activity in Membranes
1.3.1 Mechanisms for Biomembrane Transport
In addition to the transient lipid domains responsible for membrane signaling, trafficking,
and molecular transport, there are also more established and persistent modes for the transport of
5

ions and small polar molecules. The movement of ions and molecules across lipid membranes is
extremely vital for cellular functions as well as for cell survival, and therefore, it is important to
study these processes and learn more about the mechanisms through which they take place. Both
the mechanism (how ions cross the bilayer) and the stoichiometry of transport (number of ions
being shuttled) are of interest in ion transport studies.
Ion transport commonly takes place via one of two mechanisms: 1) mobile “carriers” or
2) ion channels, which are illustrated in Figure 1.2.50-52 In the mobile carrier mechanism an
ionophore shuttles ionic substrates from one side of the membrane to the other (Figure 1.2A). In
the context of this work, ionophores are defined as membrane soluble molecules that are capable
of transporting specific ions and molecules across the hydrophobic bilayer membrane.53
Although there is a large energy barrier for the transport of hydrophilic ions such as Na+, K+,
Ca+2 and Cl-, their transport is easily accomplished with the aid of ionophores, which shield their
electrostatic charges from the bilayer membrane.54

The second mode of transport via ion

channels (Figure 1.2B) facilitates ion transport by self-assembling necessary components that
result in the formation of a tunnel or pore within the membrane.55 This tunnel enables the ions to
pass through the bilayer in essentially extracellular fluid without being exposed to any
hydrophobic constituents. Whereas the mobile carriers control movement of the substrates
through recognition and signaling, the ion channels are “gated,” meaning they operate under an
open-close process in response to some cellular event.11 The stimuli that can initiate this gating
process are mechanosensitive (physical stimuli), ligand-gated (extracellular chemical stimulus),
signal-gated (intracellular stimulus) and voltage-gated channels (membrane potentials).56

6

Finally, the stoichiometry of ion transport must be considered. It is important to note that
within these mechanisms more than one substrate can be shuttled at a time. Therefore, it is
useful to describe the mediated transport process as a uniport, symport or antiport translocation
system. Uniport denotes an ionophore that translocates one substrate at a time, as shown in
Figure 1.3A, whereas symport represents the simultaneous translocation of two different ions or
molecules (Figure 1.3B). Antiport can be extremely important in counterbalancing ion transport
by transporting two different molecules in opposite directions within the bilayer (Figure 1.3C).

7

Figure 1.2: Ion Transport Mechanisms: (A) Illustration of the mobile carrier
mechanism. Substrate is able to move through the bilayer through recognition,
encapsulation and shielding by the carrier molecule. (B) Depiction of an ion channel.
Substrate moves directly through the hydrophobic membrane via an open channel that
can regulate flow.

A.) Uniport

B.) Symport

C.) Antiport

Figure 1.3: Translocation Systems: (A) Uniport – only one molecule is transported
through bilayer membrane. (B) Symport – two different molecules are transported
through membrane in the same direction. (C) Antiport – two different molecules are
transported in opposing directions through the bilayer membrane.
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1.3.2 Channelopathies
There is a strong desire among the scientific community to gain more understanding and
insight into the specific mechanisms of ion transport, as well as the resultant functions that occur
as an outcome of the ion transport. As previously stated, the transport of ions across membranes
affects a multitude of cellular operations that are essential for the existence and proper function
of the cell. Dysfunction within these transport mechanisms can lead to wide-ranging diseases,
commonly referred to as “channelopathies.”52,

57

For example, the movement of sodium and

potassium ions is crucial for nerve functioning.58 A decrease in cellular K+ levels has been
suggested to trigger apoptotic death, whereas increased cytosolic Ca+2 levels can lead to suicidal
erythrocyte death.59 Epilepsy is a neurodegenerative disease that results from mutations in
voltage-gated Na+, K+, Ca+2, or Cl- channels.60 Mutations of the cystic fibrosis transmembrane
conductance regulator (CFTR) protein lead to reductions in Cl- and water secretions in epithelial
airway surfaces, as well as the inability to absorb Na+ and water from airway surfaces.61-63 This
irregularity in ion transport leads to the removal of salt and water from airway passages, which
results in the buildup of gylcoproteins in the mucus layer.61-63 These examples alone illustrate
the crucial importance for understanding how biomembranes operate and function and therefore
the requirement for highly sensitive and specific methods for monitoring these systems. The
currently utilized methods for monitoring these events are summarized in Section 1.6.
1.3.3 Enzymes that Regulate Membrane Asymmetry
Although it may not seem directly related at first glance, the enzymes that regulate
membrane asymmetry are essential for the transport of ions and molecules throughout the cell. It
has been noted that asymmetric phospholipid distribution is vital for cell survival and can affect
9

ion channel shape and size and ionophoretic activity as well as protein signaling, fusion, blood
coagulation, and apoptosis. 64-73 Research has shown that the outer leaflet of eukaryotic cells are
enriched with phosphatidylcholine (PC) and sphingomyelin (SM), whereas the endoplasmic
leaflet is concentrated with the phosphatidylethanolamine (PE) and phosphatidylserine (PS)
(Figure 1.4).74 The approximate distribution of phospholipids between the inner and outer
leaflets of an erythrocyte membrane is presented in Figure 1.5.75

Figure 1.4: Structures of Common Phospholipids
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Figure 1.5: Distribution of Phospholipids Across an Erythrocyte Membrane*
*

Reprinted with permission from Daleke, D. L. Curr. Opin. Hematol. 2008, 15, 191. Copyright 2008
Lippincott Williams & Wilkins

Phospholipids both move laterally throughout a bilayer leaflet as well as diffuse between
the two leaflets, with the latter being the more time and energy consuming process.5, 76 There are
natural enzymes that can catalyze these processes, known as flippases, floppases and scramblases
which are shown in Scheme 1.1.77 In the case of flippases, phospholipids are translocated or
“flipped” from the outer bilayer leaflet into the cytosolic leaflet.78 Floppases do the exact
opposite, by transporting or “flopping” lipids from the internal leaflet into the external bilayer. 2,
74

Both of these processes are energy (ATP) dependent, whereas scramblases are energy

independent and move any phospholipids down its concentration gradient.2, 74, 78 Specifically,
scramblase activity leads to the controlled movement of lipids to areas within the bilayer that
have a lower concentration of that particular lipid (toward equilibrium), either laterally or
between the two bilayer leaflets.3 This activity is increased in the presences of Ca2+.2, 74, 78
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Scheme 1.1: Enzyme Promoted Flip Flop in a Bilayer Membrane

The loss of asymmetry within a membrane can occur in both normal and pathologic
situations.74 For example, the controlled movement of PS to the cytosolic leaflet is a trigger for
cell death and subsequent removal by phagocytosis,2, 79 while the unregulated translocation of
PS to the outer leaflet can contribute to cardiovascular diseases, stroke and diabetes.74
Therefore, synthetic molecules80-83 and peptide analogs84,

85

capable of lipid flipping can be

considered as developmental therapeutics for several specific disorders86,

87

such as Scott

syndrome and vascular complications in Alzheimer’s disease.88, 89 Furthermore, flip of cationic
lipids may greatly improve the efficiency of non-viral gene delivery systems.90 Consequently,
lipid flip detection assays, which allow the monitoring of the activity of these enzymes and their
analogs, are in high demand. The currently utilized assays are introduced in the following
section (1.5) along with the inherent deficiencies that lead to the need for new assays.
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1.4 Application of Liposomes as Model Membranes
As previously mentioned, membranes not only provide the structural barrier of cells but
they are also responsible for multiple cellular functions. Biomembranes include a number of
lipids and phospholipids, which consist of three main groups, the glycerol-based lipids,
cholesterol and sphingoid-based lipids.91 Biomembrane systems also contain proteins that are
responsible for cell transport and cell-signaling.

Due to the diverse complexity of these

biomembranes, it is often desirable to have a simpler model when studying particular elements.
The implementation of model membranes, known as liposomes or vesicles (used
interchangeably), was first recognized in 1965 by Bangham.92,

93

Since their establishment,

liposomes have been employed in drug delivery, gene therapy, disease treatment, immunoassays
and many more areas that have been subject of many excellent review articles.12, 94-97
Liposomes are similar to cell membranes since they can be formulated to contain a
bilayer membrane; however, the internal and external contents can be controllably altered with
respect to the number of lipids, proteins and enzymes they contain. These bilayers can be
tailored to differing levels of complexity; from only one type of phospholipid with no proteins to
multiple types of lipids and proteins. They can also be custom-made to contain one bilayer,
known as unilamellar, or multiple layers like that of an onion, known as multilamellar. Typical
sizes range from anything less than 100 nm in diameter in small unilamellar vesicles (SUVs) to
anywhere between 100 nm and 1000 nm for large unilamellar vesicles (LUVs).94, 98 Giant
unilamellar vesicles (GUVs) are considered to be larger than 1000 nm. 94, 98
Within the studies described in this work, we utilized LUVs that are approximately 120130 nm in size which have been prepared by high pressure extrusion and contain egg yolk
13

phosphatidylcholine (EYPC).99,

100

[The predominant species in the EYPC was C42H82NO8P,

18:1 (Δ9).] In this approach, initial formation of LUVs is accomplished through the addition of
aqueous buffer to the desired solution of phospholipids, which are dissolved in an organic
solvent. After mixing the contents the organic solvent is removed under reduced pressure to
form a thin film. The desired internal aqueous solution is then added and a series of freeze-thaw
cycles generally form LUVs, whose size is altered through high pressure extrusion through a
polycarbonate membrane of a defined pore size.100
1.5 Current Methodologies for Monitoring Membrane Transport/Activity
This first chapter has only briefly introduced the plethora of possible methods by which
substrates are transported across a bilayer membrane. One can therefore imagine that there is an
immense need for multiple, highly sensitive, versatile assays to monitor not only whether
transport is taking place but also the mechanisms by which the transport occurs. In Section 1.3
some of the various mechanisms by which ions, lipids and substrates are transported across a
biological membrane were introduced. It is important to note that various methodologies are
currently employed for studying biomembrane events; however, each one of these methods
contains imperfections and sometimes even discrepancies with results from alternative methods.
The remainder of this section will be devoted to briefly describing various methodologies for the
detection of ion transport and the mechanisms through which it occurs, as well as, lipid flip
activity.
1.5.1 23Na NMR
NMR spectroscopy can be utilized for determining the activity of ionophores in vesicles.
The major advantage to using NMR spectroscopy is that it is a direct method of analysis, in
14

contrast to fluorescent studies, which commonly use a pH sensitive dye such as 8hydroxypyrene-1,3,6-trisulfonate (HPTS, pyranine) to indirectly monitor the movement of ions
through a bilayer membrane. Additionally, NMR is advantageous for in vivo studies due to its
non-invasive nature.101 Researchers including Regan102, Riddell103 and Gupta104 have developed
a series of NMR experiments that can directly measure the transport of ions by tuning the NMR
probe to 7Li, 23Na, 39K, and 35Cl.
The most commonly used NMR transport experiments follow the transport of sodium
ions. In a typical 23Na NMR experiment, a set of vesicles is formulated with the same amount of
internal vs. external Na+ ions.105 In order to discern the difference between the intracellular and
extracellular NMR signals, the addition of a membrane impermeable shift reagent containing
(Dy3+)102, 104, 106-108, (Gd3+)104, 109-111 or (Tm3+)112-115 on either side (internal or external) of the
liposomes is necessary. Complexation of the shift reagent with

23

Na+ ions allow for a chemical

shift difference to occur between the free and the bound 23Na+ ions. Furthermore, the addition of
a membrane active ionophore will lead to exchange of

23

Na+ ions within the two environments

and a corresponding change in the NMR signals.51
Although dynamic NMR spectroscopy can be an extremely efficient method for
determination of the activity of ionophores, it also contains many inherent deficiencies. It is a
time-consuming process that necessitates extensive initial training for the researcher, a
significant amount of time to gather real-time data for the ionophoretic activity, and a high cost
for the chemical shift agents. The analysis of

23

Na+ ions is convenient because of its large

magnetogyric ratio, moderate quadrupole moment and large natural abundance (100%).116
However, if studies require the analysis of the transport of other ions such as (Li+)117-121, (K+)12215

126

or even (Cl-),127-129 this can become increasingly cumbersome and time consuming due to any

combination of factors such as competitive binding, different magnetogyric ratios and/or lower
natural abundances.130 It has also been shown that this technique can be somewhat “user”
dependent and results can vary between repeated experiments.11 This method can be very good
for determining whether or not ion transport is taking place; however, it is less amenable to
kinetic studies.51 It has also been shown that certain chemical shift reagents can be toxic131 and
disruptive toward liposomes, leading to fusion129, 132 or rupture129, 133 of vesicles. The potential
for competitive sodium binding with substrates other than the shift reagent must also be
considered.134 Lastly, the analysis of the kinetics of binding can also be problematic if they
occur too fast on the NMR timescale.129
1.5.2 Conductance Methodologies: Voltage Clamp, Patch-Clamp, Planar Bilayer
Voltage Clamp
The voltage clamp method was invented in the 1950’s through a compilation of research
by different people.135 Most notable of all this work was probably that of Alan Hodgkin and
Andrew Huxley, who carried out a series of experiments that led to the discovery of electric
current in cell membranes for which they were awarded a Nobel Prize for Physiology or
Medicine in 1963.136 Briefly, the voltage clamp method contains two sharp tip electrodes, one of
which remains in the extracellular matrix and another that pierces the cell membrane placing it in
the cell cytoplasm.136 Having an electrode in two different cellular environments allows for any
differences in impulse generation to be recorded. The inherent disadvantages with this method
are the excessive background noise and the fact that physiological conditions are altered by
piercing the membrane with the electrode.
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This significant milestone in electrophysiology was revolutionized in the 1960’s when
Erwin Neher and Bert Sakmann developed the patch clamp technique, work which was also
recognized with the Nobel Prize for Physiology or Medicine in 1991.137, 138 The patch clamp
method has been extensively applied to the study of ionophores and is considered to be one of
the most predominant methods.139-141
Neher and Sakmann were able to avoid the disadvantages of the voltage clamp method by
using a metal coated glass pipette that forms a tight seal with the bilayer membrane.137 The
electrical properties of this tight seal range on the order of 1010 Ohms and is referred to as a
“gigaseal.”137

The gigaseal drastically decreases background noise, increases sensitivity of

measurements, and can allow measurements within either the whole-cell or a selected, excised
patch of the membrane. During these experiments, researchers can monitor either all channel
activity or single ion movement between the bilayer membrane and the pipette, depending on the
chosen recording configuration. An excellent review by Liem et al. summarizes a series of
available experimental protocols within this design.140 The resultant spectra from ion channel
behavior (open and close functions) are recorded as a square wave function.11
One of the largest limitations of the patch clamp method is the large time requirement142
for experiments as well as the need for a highly trained and experienced operator.143 Within
certain protocols of the patch-clamp experiment, drawbacks can include the release and
exchange of interior cell contents, such as organelles and ionophores of interest, into the pipette
or bath solution.140,

144

Additionally, it is possible to obtain erroneous recordings of channel

activity or results that may not be reflective of the entire cell.140 Some researchers also believe
that the stress placed on the membrane in a patch clamp experiment can lead to inaccurate
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results.145 However, even with these possible drawbacks this method is still considered to be a
gold-standard, yielding invaluable information about channel activity. 70,156
Due to the need for experiments with higher-throughput and higher sensitivity, there have
been a series of advances that have yielded vast improvements within this technique.52, 141 One
such advancement was the development of planar bilayer voltage clamp (PBVC) experiments,
which utilize two separate buffer-containing cells (containing Ag/AgCl reference electrodes) that
are connected by a small pinhole.11, 146 The bilayer membrane is then ‘painted’ onto this small
aperture. Although there are fewer configurations within this method than the patch-clamp
technique, the internal and external solutions can be exchanged very readily. Recently there has
been a strong push to develop higher-throughput systems using chip-based PBVC platforms.147
1.5.3 Liposome Based pH-stat Fluorometric Assay
One commonly utilized assay for the detection of physiologically relevant ionophore
activity is the liposome based pH-stat fluorometric assay. This assay monitors the fluorescence
intensity of a pH-sensitive dye, usually 8-hydroxypyrene-1,3,6-trisulfonate (HPTS, pyranine)
shown in Scheme 1.2A, but sometimes fluorescein.148-152 Pyranine is advantageous for studying
biological systems since its pKa (7.2) is close to that of physiological pH. 153 Additionally, the
protonated and deprotonated forms of this dye are excited at different wavelengths (405 and 460
nm respectively) but both emit at the same wavelength (510 nm).153 Therefore, the indirect
monitoring of the fluorescence ratio of the protonated: deprotonated forms of pyranine dye can
reveal the pH of a solution.153, 154
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Scheme 1.2: pH-Stat Experiment: (A) Structure of pyranine dye. (B) The
fluorescence of the pH-sensor pyranine in liposomes is monitored as a function of
time; the H+ release is a result of exogenous application of the base and ionophore.

In this experiment (Scheme 1.2B), a controlled amount of base and a potential ionophore
are added to a suspension of liposomes that have been preloaded with HPTS dye (100 μM). 155
The addition of the external base leads to a difference in the intra- and extravesicular pH,
resulting in a gradient across the bilayer membrane, which leads to the efflux of hydronium ions.
The resultant buildup of electrostatic potential can be compensated for by either the influx of
cations or the efflux of anions from the liposomes. If the compound of interest mediates such ion
transport, the efflux of hydronium ions continues altering the intravesicular pH and the
fluorescence of the reporter dye. The kinetic trace obtained from the dye response thus reflects
the ionophoretic activity of the studied compound. While the major advantage of this method is
its rapid and reliable results, the pH-stat assay provides little information on the mechanism of
ion transport.1 One can only determine whether or not an ionophore is properly functioning.
Also, the results of the pH-stat assay do not always correlate with other methods of study.156-158
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1.5.4 Calcein Based Assay
Although the pH-stat assay lacks details on the mechanism of ion transport, a membrane
leakage assay can reveal some mechanistic aspects by distinguishing selective ion transport from
nonselective leakage through oversized pores. This assay utilizes the fluorescent dyes, shown in
Scheme 1.3A, calcein or carboxyfluorescein (CF) and its fluorescent self-quenching which
occurs at very low concentrations (approximately 100 mM).159, 160
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Scheme 1.3: Membrane Leakage Assay: (A) Structure of calcein dye. (B)
LUVs containing calcein are probed with the ionophore. In the case of large
pore formation, the self-quenching dye is released and restores the emission.
In a typical experiment (Scheme 1.3B), a set of liposomes containing the concentrated
dye is challenged with the ionophore of interest. This assay is crucial for determining whether or
not an ionophore is acting by means of selective ion leakage or through massive leakage through
large pores. In the case of selective ion transport, little change in fluorescence is observed, since
the larger calcein dye will not likely be transported by selective ionophores. However, larger
pore formation, such as that arising from introduction of melittin,161 results in the release of dye,
its subsequent dilution, and an emission increase.
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Therefore this assay can reveal limited

information about the size and selectivity of channel activity in the specific case of large pore
formation. However, whereas the pH-stat assay is based on LUVs containing the dye at low
concentration (100 μM), the high concentration of the dye in the membrane leakage assays (100
mM) could alter the bilayer properties, change the buffer capacity, and interact with the
ionophore. For optimal compatibility and reliability, the same LUVs should be utilized in both
pH-stat and membrane leakage assays.
1.5.5 Endovesiculation Studies with DPX
A similar problem to the previously mentioned membrane leakage assay also exists with
an assay applied to the detection of the endovesiculation process.

Endovesiculation is a

mechanistic analogue of cellular endocytosis, which was previously discussed (Section 1.2.2). In
these experiments (Scheme 1.4), a set of liposomes is incubated with exogenous pyranine dye
and an endovesiculogen such as chlorpromazine or imipramine.25, 26, 162 Once this is completed,
any extravesicular dye must be quenched with a membrane-impermeable quencher such as pxylene-bis-pyridinium bromide (DPX) at a concentration of 40 mM. Any pyranine that is
entrapped during endovesiculation will be inaccessible to the quencher and remain fluorescent.
This residual fluorescence therefore serves as a measure of the extent of endovesiculation.
Unfortunately, it has been reported that DPX can affect the fluidity of negatively charged
membranes, alter the size of liposomes, and lower the bilayer phase transition temperatures at
millimolar concentrations.163

In order to avoid these undesirable events and possible

misinterpretation of results, a fluorescence quencher operating at a much lower concentration
than that currently used for DPX is required for greater accuracy of endovesiculation detection
studies.
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Scheme 1.4: Endovesiculation Detection: Liposomes are incubated with pyranine and
endovesiculogen, followed by the fluorescence quenching with DPX; the residual
fluorescence of entrapped dye serves as a measure of endovesiculation extent.
1.5.6 (NBD-PE)-Sodium Dithionite Assay
In addition to studying the aforementioned membrane events, a method for the detection
of lipid flip within bilayers is also in high demand. Section 1.3.3 introduced some enzymes that
are responsible for membrane asymmetry and lipid translocation.

Lipid translocation is

associated with apoptosis, blood clotting and several other disorders previously described
(Section 1.3.3). Although there are currently employed lipid flip detection assays that enable the
monitoring of flippases, floppases and scramblases, as well as their fully synthetic and peptide
analogues, these assays contain inherent deficiencies that need to be addressed.
To date, three major assays are utilized for the monitoring of lipid flip in model spherical
bilayers (liposomes). The first method relies on the flip of transferable fluorescent 7-nitro-1,2,3benzoxadiazol-4-yl (NBD)-labeled lipid from the donor liposomes to the acceptor liposomes
containing non-transferable rhodamine-labeled lipid that serves as a fluorescence quencher.164
The second methodology is based on removal of the fluorescent lipid165 from the bilayer outer
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leaflet by incubation with serum albumin.166 The most conventional way for detection of
flippase activity is based on the irreversible quenching of the fluorescence of NBD-labeled lipids
in cells167 or liposomes

168, 169

with 10-60 mM sodium dithionite (Na2S2O4, Scheme 1.5). The

extent of lipid flip is assessed from the residual fluorescence of liposomes after the application of
the quencher.

Due to its anionic character, dithionite exhibits low permeability to the

hydrophobic bilayer membrane and therefore does not rapidly quench the fluorescence of the
lipid located on the inner bilayer leaflet. However, it quickly quenches the fluorescence of lipid
residing on the outer leaflet. The assay has numerous intrinsic deficiencies arising from the high
concentration of the quencher required for the assay, the reductive nature of this reagent, and
some permeability of the quencher to the bilayer membrane. Thus, it has been shown recently
that sodium dithionite diffusion through the bilayer is similar to or faster than that of
unfacilitated lipid flip.170 Potentially, dithionite can reduce the disulfide cross-links found in
some flippases.

For example, wild type human P-glycoprotein (Pgp), which is a known

flippase,171 facilitates the lipid flip to a lesser extent than Pgp treated with the reducing agent due
to the inhibitory disulfide cross-links between nucleotide binding sites.172

In contrast, the

Scheme 1.5: Representation of Lipid Flip Detection Assay: LUVs containing
fluorescently labeled lipids are treated with membrane-impermeable quencher.
Alterations in the residual fluorescence of the lipids from inner bilayer leaflet serve as the
measure of lipid flip.
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activity of human scramblase protein is suppressed by reducing reagents due to the reduction of
disulfide cross-links.173 These examples demonstrate that dithionite may affect the flipping
activity of enzymes in a dual way and, therefore, cannot be reliably used in real time monitoring
experiments.
1.6 Thesis Outline
This introduction has been devoted to presenting the importance of biomembranes, some
of their primary functions and the necessity to monitor their activity and the action of proteins
and enzymes within them. Section 1.5 gave a brief introduction into some of the most current
methods used to monitor the activities of membrane leakage and lipid flip as well as their
inherent deficiencies. It has been noted that fluorescence-based methodologies are a relatively
simple, highly sensitive, versatile and inexpensive approaches for the study of biomembrane
events.174 Many recent reviews outline the vast array of optical techniques that are currently
utilized in the imaging of membranes.10,

175, 176

Within all of these methods, the cellular

processes are monitored by introducing either fluorescent probe molecules (Sections 1.5.3-1.5.5)
or previously labeled lipid probes along with the reporter molecules (Section 1.5.6).
Unfortunately, the assays currently employed operate with high millimolar concentrations
of small probe compounds that can interfere with membrane studies.177,163 Specifically, this can
lead to undesirable interactions with membrane properties, alter the normal cellular activity, and
interfere with the specific proteins and enzymes that are being monitored.178-181 Therefore, there
is a necessity for the development of highly sensitive fluorescent sensors that can decrease the
required concentrations of probe compounds, thereby avoiding high levels of toxicity, high cost
of production, and competitive binding of foreign substrates.182-184 This dissertation specifically
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concentrates on the need for the development of new fluorometric assays that monitor membrane
leakage and lipid flip. In addition, the newly developed methodology is applied toward the
development of a step-wise content release drug delivery system.
In Chapter 2, a newly developed membrane leakage assay is presented.185 Our efforts
began with the synthesis of a new receptor, which we named cyclen 1, which is highly selective
for anionic pyrene-based dyes and comprised of four naphthylthiourea groups tethered to a
cyclen core via an ester linkage. We hypothesized that this membrane impermeable receptor
would selectively quench the fluorescence of a pH-sensitive dye pyranine at micromolar
concentrations (Scheme 1.6A). Visual evidence of the fluorescence quench of pyranine dye (1
μM) in the presence of 25 μM cyclen 1 is shown in Scheme 1.6B (left vial). This is a substantial
improvement upon the currently utilized membrane leakage assay which requires high
concentrations (100 mM) of pyrene dye. This new methodology is fully compatible with the pHstat assay and allows for differentiation between ion transport and nonselective leakage
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Scheme 1.6: Cyclen 1 Binding to HPTS: (A) Proposed binding mode for Cyclen 1 and
pyranine dye. Note: the backside unit of thiourea has been truncated for clarity. This
picture is speculative and for pictorial purposes only. (B) Visual evidence of pyranine
fluorescence quench. Both vials contain a 1 M solution of pyranine (HPTS) dye,
however, whereas the right vial does not contain any Cyclen 1, the left vial contains 20
M of Cyclen 1.
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mechanisms within a singles set of experiments. Additionally this new assay is operational at
near-physiological pH with fast kinetics of binding. The specificity of the cyclen 1 receptor for
pyrene-based dyes was characterized by a series of 1H-NMR, microcalorimetry, UV-vis and
fluorometry experiments.
In Chapter 3, a novel lipid flip detection assay is presented.186 As an extension of our
previous work, we decided to pursue the development of a fluorescently labeled lipid that could
bind with the new synthetic receptor, cyclen 1.

We hypothesized that a lipid probe that

contained a similar periphery and scaffold to that of HPTS dye would also yield high selectivity
and rapid kinetics of binding with cyclen 1. A new cascade-blue-labeled lipid allowed the
development of a replacement assay for the commonly utilized NBD-dithionite methodology,
which was operational at micromolar concentrations and did not interfere with membrane
integrity. Whereas fluorescence quenching of the NBD group is accomplished through its
chemical modification in the traditional NBD-dithionite assay, the new assay relies on the noncovalent interactions between the cascade-blue label and the receptor (Figure 1.6). Therefore,
the quenching can be reverted by either competitive displacement of the lipid-attached label with
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Figure 1.6: Lipid Flip Detection Assay Components: (A) Cyclen 1 fluorescence
quencher (B) The cascade-blue labeled lipid used to bind with cyclen 1
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a water-soluble substrate, or by enzymatic degradation of the receptor leading to the label release
and fluorescence quenching. We demonstrate that this new methodology is suitable for the study
of lipid flip in both model spherical bilayer membranes and in-vitro experiments.
In Chapter 4, the application of the new membrane leakage assay toward monitoring the
development of a step-wise content release drug delivery system is discussed. Within these
studies a series of new pH-sensitive lipids were synthesized to be utilized in liposomes that
contain varying amounts of NaCl in their internal compartments. After addition of an HCl cotransporter and an exogenous solution of NaCl, each set of liposomes begins to undergo internal
acidification. This is due to the uptake of HCl by the co-transporter, which is responding
proportionally to the Cl- gradient across the liposomes that contain differing amounts of internal
NaCl.

Over time, the internal acidification of liposomes leads to the hydrolysis of the pH-

sensitive lipids and subsequent contents release at the desired time (Figure 1.7). This stepwise
content release system could potentially be applied to a drug release system, where stages of

HCl transporter
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NaCl

pH 5.6
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NaCl

pH 6.5

pH 6.5
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NaCl

pH 7.2

pH 7.2

pH 7.2

time course

Figure 1.7: Stepwise Release of Liposome Contents Triggered by a
Single Application of HCl Co-Transporter
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contents release are separated by periods of low activity. The conclusions from this preliminary
work as well as future work will be presented in this chapter.
1.7 Conclusions
The strict regulation of cellular processes is vital for cell survival, and deficiencies within
these cellular pathways can lead to various channelopathies. Therefore, methodologies for
monitoring specific processes such as exocytosis, endocytosis and apoptosis are in high demand.
Current methodologies for monitoring biomembrane activity range from nuclear magnetic
resonance, patch clamp and a wide range of fluorometric assays. Unfortunately, many of these
widely accepted protocols contain inherent deficiencies that necessitate improved methodologies.
Therefore, this work focuses on the development of cyclen-thiourea based receptors
which have a high affinity for fluorescent dyes. These receptor-fluorescent dye pairs provide a
non-invasive, physiologically compatible, accurate methodology suitable for the study of
membrane leakage and lipid flip events, which are both critical processes in cellular membrane
activity. The approaches described within this work address intrinsic deficiencies that have been
observed in widely accepted protocols. Those protocols show undesirable interactions with the
bilayer membranes due to the small nature of the molecular probe compounds utilized, which
tend to have lower binding affinities requiring higher concentrations.

A macromolecular

approach that can increase the specificity of binding, thereby lowering concentrations of the
probe compounds used in the fluorometric detection of biomembrane events, is in high demand
by the biochemical community and a target for developmental pharmaceuticals. These receptordye complexes provide useful insight into biomembrane processes and allow the development of
a newly-designed drug delivery system.
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Chapter 2
Receptor for Anionic Pyrene Derivatives Provides the Basis
for New Biomembrane Assays
This chapter was reproduced with permission from J. Amer. Chem. Soc. 2005, 127, 1470414713 from the American Chemical Society.
Christine A. Winschel, Amar Kalidindi, Ibrahim Zgani, John L. Magruder, and Vladimir Sidorov*
Contribution from the Department of Chemistry, Virginia Commonwealth Univeristy, Richmond,
Virginia 23284-2006; E-mail: vasidorov@vcu.edu

2.1 Abstract
This study describes a new receptor cyclen 1 capable of strong selective binding of
pyrene-based anionic dyes under near-physiological conditions. This receptor comprises four
naphthylthiourea groups tethered to a cyclen core via an ester linkage. The complexation
behavior of cyclen 1 receptor is characterized by a series of 1H NMR, microcalorimetry, UV-vis,
and fluorometry experiments.

The relevance of structural features of this receptor to its

recognition function is assessed using control compounds that lack some of the groups found in
cyclen 1. The specificity of cyclen 1 toward pyrene-based dyes is assessed through experiments
using dyes with different molecular organization. The most important finding was the ability of
cyclen 1 to bind efficiently to a pH-sensitive pyranine dye, a dye that is commonly used in
various biomembrane assays. The high affinity of cyclen 1 to pyranine, its impermeability to the
lipid bilayer membrane, fast kinetics of binding, and ability to quench the pyranine’s
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fluorescence were used as a basis for a new membrane leakage assay. This membrane leakage
assay is fully compatible with the commonly applied pH-stat transport assay, and therefore it
allows for differentiation of the ion transport and nonselective leakage mechanisms within a
single set of experiments. The ability of cyclen 1 to quench the fluorescence of pyranine also
finds limited applicability to the detection of endovesiculation.
2.2 Introduction
Synthetic ionophores187 have shown promise as a basis for new antibiotics,188-191
therapeutics or genetic diseases,128, 192-194 sensors,195-197 and enzyme mimetics.198-200 As a result,
there is a growing need for the development of assays to rapidly assess the activity of such
compounds under near-physiological conditions. Along with 23Na NMR201-205 and planar bilayer
voltage-clamp206-209 (PBVC) experiments, the liposome-based pH-stat fluorometric assay is an
assay routinely used for identification of physiologically relevant ionophores (Chart 2.1A).155
In this assay, a controlled amount of base and potential ionophore is added to a suspension of
liposomes containing a pH-sensitive dye, 8-hydroxypyrene-1,3,6-trisulfonate (HPTS, pyranine),
or sometimes fluorescein.148-152 Pyranine is preferred due to the pKa value complying with the
physiological pH range and two distinct excitation maxima found for its protonated and
deprotonated forms. The ratiometric monitoring of pH using these two excitation maxima makes
the observed response independent from pyranine concentration. The resulting pH gradient
across the bilayer membrane causes the efflux of hydronium ions and builds up an electrostatic
potential. This potential can be compensated by the efflux of anions or influx of cations. If the
compound of interest mediates such ion transport, the efflux of hydronium ions continues
altering the intravesicular pH and the fluorescence of the reporter dye. The kinetic trace obtained
from the dye response thus reflects the ionophoretic activity of the studied compound. While
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being rapid and reliable, the pH-stat assay provides little information on the mechanism of ion
transport.1 PBVC experiments provide mechanistic information in high detail;1 however, these
methods often lack reproducibility and require specific skills and an extensive time
investment.156, 157, 207 The results of pH-stat and PBVC experiments do not necessarily correlate
due to the difference in membrane models and experimental conditions.156-158
A membrane leakage assay addresses some mechanistic aspects by distinguishing
selective ion transport from nonselective leakage through oversized pores (Chart 2.1B).159, 160

Chart 2.1: (A) pH-Stat Experiment;a (B) Membrane Leakage Assay;b (C) Endovesiculation
Detection aThe fluorescence of the pH-sensor pyranine in liposomes is monitored as a
function of time; the H+ release is a result of exogenous application of the base and
ionophore. bLUVs containing calcein are probed with the ionophore. In the case of large
pore formation, the self-quenching dye is released and restores the emission. cLiposomes are
incubated with pyranine and endovesiculogen, followed by the fluorescence quenching with
DPX; the residual fluorescence of entrapped dye serves as a measure of endovesiculation
extent.
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This assay utilizes the ability of calcein or carboxyfluorescein (CF) dyes to self-quench their
fluorescence emission at ~100 mM concentration. In a typical experiment, a set of large
unilamellar vesicles (LUVs) containing the concentrated dye is challenged with the compound of
interest. In the case of selective ion transport, little change in fluorescence is observed, whereas
the larger pore formation results in the dye release, its subsequent dilution, and emission
increase. However, whereas the pH-stat assay is based on LUVs containing the dye at low
concentration (100 μM), the high concentration of the dye in leakage assays (100 mM) could
alter the membrane properties, change the buffer capacity, and interact with the ionophore. For
optimal compatibility and reliability, the same LUVs should be utilized in both pH-stat and
membrane leakage assays.
As one of the reviewers pointed out, a similar problem exists with an assay applied to the
detection of the endovesiculation process, a mechanistic analogue of cellular endocytosis. 25,
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Endovesiculation is detected through the incubation of liposomes with exogenous pyranine and
endovesiculogen, followed by the quench of extravesicular dye with the membrane-impermeable
dynamic quencher p-xylene-bis-pyridinium bromide (DPX) at 40 mM concentration (Chart
2.1C). The portion of the dye entrapped during endovesiculation is inaccessible to the quencher
and remains fluorescent. This residual fluorescence serves as a measure of the endovesiculation
extent. It has been reported that DPX affects the fluidity of negatively charged membranes,
alters the size of LUVs, and lowers the bilayer phase transition temperatures at millimolar
concentrations.163

To avoid all these artifact events and misinterpretations of results, a

fluorescence quencher operating at much lower concentration than currently used DPX is
required for endovesiculation detection.
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2.3 Experimental Section
2.3.1 General
The 1H NMR spectra were recorded on a Varian AS400 instrument operating at 400.130
MHz or a Varian Mercury instrument operating at 299.865 MHz. Chemical shifts are reported in
ppm relative to the residual protonated solvent peak. The 13C NMR spectra were recorded on the
same instruments at 100.613 and 75.408 MHz, respectively, and chemical shift values are
reported in ppm relative to the solvent peak. Both 1H and

13

C spectra were taken in the same

solvent and on the same instrument for each sample. The low-resolution mass spectra were
recorded on a Micromass Q-TOF 2 instrument (Manchester, U.K.) using the electrospray
technique (positive mode). The samples were introduced into a mass spectrometer using a flow
rate of 10 μL/min, the needle voltage was set at 3500 V with ion source at 110°C, and the cone
voltage at 35 V.

The high-resolution mass spectra were recorded on a LCMS-IT-TOF

(Shimadzu Corporation, Columbia MD) instrument using the electrospray technique (positive
mode).

All spectrophotometric experiments were carried out on a Fluoromax 3 (Jobin-

Yvon/Horriba) spectrophotometer.

The dynamic light-scattering analysis of the liposome

suspensions was carried out on the Malvern instrument (Malvern Zetasizer Nano Series, Malvern
Instruments). Microcalorimetric titrations were performed using a VP-ITC microcalorimeter
(MicroCal, LLC, Northampton MA), and the ORIGIN-7 software was used to calculate the
binding constants and the enthalpy changes. The pH of solutions was monitored with a Corning
350 pH/ion analyzer, using a Ag/AgCl pH-sensitive electrode (Accumet). Chromatography was
performed using 60-200-mesh silica purchased from Baker and 40-120 μm Sephadex G-75
purchased from Aldrich. Thin-layer chromatography was performed on Kieselgel 60 F254 and
Uniplate Silica Gel GF silica-coated glass plates and visualized by UV and I2. High-pressure
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extrusion was performed on the Avanti mini-extruder with a 0.1 μm polycarbonate membrane.
All chemicals, solvents, and dyes were purchased from Aldrich, Sigma, Fluka, and Invitrogen.
Egg yolk phosphatidylcholine was purchased from Avanti Polar Lipids.

2.3.2 Synthesis

The synthetic scheme for compounds 1-3 is shown in Scheme S1 of Appendix A, and the
synthetic procedure for compound 4 is shown in Scheme S2 of Appendix A.

Bromoacetic Acid 2-t-Butoxycarbonylaminoethyl Ester 1a. tert-Butyl-N-(2-hydroxy ethyl)
carbamate (4.5 g, 28 mmol) was dissolved in dichloromethane (30 mL), and triethylamine (3.9
mL, 28 mmol) was added. The mixture was stirred for 10 min at room temperature, and
bromoacetyl bromide (3.15 mL, 36 mmol) was added dropwise within 5 min. The reaction
mixture was stirred for 5 h at room temperature, the solvent was removed under reduced
pressure, and the crude solid was purified by column chromatography (silica gel, CH2Cl2/EtOAc
4:6) to give 7.0 g of product 1a (25 mmol, 90%). 1H NMR (300 MHz, DMSO-d6, δ): 6.94 (t, 1
H, J = 5.7, 5.4 Hz), 4.11 (s, 2 H), 4.06 (t, 2 H, J = 5.7, 5.4 Hz), 3.15 (td, 2 H, J = 5.7, 5.7 Hz),
1.35 (s, 9 H);

13

C NMR (DMSO-d6, δ): 167.7, 156.3, 78.5, 65.1, 39.3, 28.8, 27.9. MS (ESI)

([M+Na] +): 304.01, calcd for C9H16BrNO4Na 304.02.

[4,7,10-Tris-(2-tert-butoxycarbonylamino-ethoxycarbonylmethyl)-1,4,7,10-tetraazacyclododec-1-yl]-acetic Acid 2-tert-butoxycarbonylamino-ethyl Ester (cyclen NH-Boc) 3.
Cyclen (0.4 g, 2.3 mmol), sodium carbonate (2.19 g, 20.7 mmol), and bromoacetic acid 2-tertbutoxycarbonylamino ethyl ester (3.8 g, 13.8 mmol) were suspended in 20 mL of acetonitrile.
The reaction mixture was stirred for 72 h at room temperature, and the solvent was removed
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under reduced pressure. The solid residue was purified by column chromatography (silica gel,
CH3OH/CHCl3 5:95) to afford 1.28 g of cyclen NH-Boc 3 (1.3 mmol, 56%).

1

H NMR (400

MHz, DMSO-d6, δ): 6.89 (t, 4 H, J = 5.6, 6.0 Hz), 4.03 (br s, 8 H), 3.15 (br s, 8 H), 2.95-2.64 (br
m, 16 H), 1.34 (s, 36 H); 13C NMR (DMSO-d6, δ): 174.0, 156.4, 78.5, 64.4, 55.4, 50.4, 28.8. MS
(ESI, high-resolution) [M+H]+, rel intensity 100.00: 977.5734, calcd for C44H81BrN8O16
977.5765; [M+Na]+, rel intensity 20.90: 999.5611, calcd for C44H80BrN8O16Na 999.5585.

(4,7,10-Tris-[2-(3-naphthalen-1-yl-thioureido)-ethoxycarbonylmethyl]-1,4,7,10-tetraazacyclododec-1-yl)-acetic Acid 2-(3-naphthalen-1-yl-thioureido)-ethyl Ester 1. Cyclen NHBoc 3 (1.0 g, 1 mmol) was dissolved in 10 mL of CH2Cl2, and trifluoroacetic acid (8 mL of 50%
v/v solution in CH2Cl2) was added dropwise. The reaction mixture was stirred for 6 h at room
temperature, and the solvent and excess of trifluoroacetic acid were removed under reduced
pressure to afford crude deprotected cyclen 1b tertrafluoroacetate (0.623 g, 0.603 mmol).
Deprotected cyclen 1b was reacted without further purification. The total amount obtained was
dissolved in 15 mL of isopropyl alcohol, and 1-naphthyl isothiocyanate (1.5 g, 8 mmol) was
added. After 15 min, triethylamine was added slowly to bring the pH to 9. The reaction mixture
was stirred for 12 h at room temperature and then evaporated to dryness under reduced pressure.
The crude solid was purified by column chromatography (silica gel, CH3OH/CHCl3 5:95) to
afford 0.26 g of pure cyclen 1 (0.2 mmol, 20% in two steps). 1H NMR (400 MHz, DMSO-d6, δ):
9.64 (s, 4 H), 7.92-7.81 (br m, 12 H), 7.51-7.41 (br m, 20 H), 4.17 (br s, 8 H), 3.72 (br s, 8 H),
2.92 (br s, 8 H), 2.63-2.63 (br m, 16 H);

13

C NMR (DMSO-d6, δ): 182.8, 174.0, 134.6, 130.4,

128.8, 128.3, 127.5, 126.9, 126.6, 126.4, 125.8, 123.5, 63.6, 55.4, 50.8, 43.4. MS (ESI, high-
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resolution) [M+H]+, rel intensity 100.00: 1317.4850, calcd for C68H77N12O8: 1317.4865;
[M+Na]+, rel intensity 36.12: 1339.4681, calcd for C68H76N12O8Na 1339.4684.

(4,7,10-Tris-[2-(3-phenyl-thioureido)-ethoxycarbonylmethyl]-1,4,7,10-tetraaza-cyclododec1-yl)-acetic Acid 2-(3-phenyl-thioureido)-ethyl Ester 2. This compound was synthesized from
cyclen NH-Boc 3 (0.6 g, 0.61 mmol) and phenyl isothiocyanate (0.6 mL, 5 mmol) according to
the procedure described for the synthesis of cyclen 1. The isolated yield of cyclen 2 was 0.12
mmol, 23%. 1H NMR (400 MHz, DMSO-d6, δ): 9.62 (br s, 4 H), 7.91 (br s, 4 H), 7.34-7.26 (br
m, 16 H), 7.10-7.06 (t, 4 H), 4.22 (br s, 8 H), 3.73 (br s, 8 H), 2.94 (br s, 8 H), 2.67-2.63 (br m,
16 H); 13C NMR (DMSO-d6, δ): 181.4, 174.0, 139.7, 129.3, 124.9, 123.7, 63.8, 55.5, 50.8, 43.1.
MS (ESI) ([M+Na]+):1139.3, calcd for C52H68N12O8Na 1139.40.

1-(2-Hydroxy-ethyl)-3-naphthalen-1-yl-thiourea 4a.

This compound was synthesized

according to the literature.210 2-Ethanolamine (0.18 mL, 2.7 mmol) was dissolved in 6.5 mL of
EtOAc, and 1-naphthyl isothiocyanate (0.502 g, 2.7 mmol) was added. The reaction mixture was
stirred for 20 min at room temperature. The white precipitate that was formed was washed with
ethyl acetate, filtered, and purified by column chromatography (silica gel, EtOAc/CH2Cl2 9:1).
Final recrystallization of the product from toluene gave 0.538 g of 4a (2.19 mmol, 81%).

1

H

NMR (DMSO-d6, 25°C, δ): 9.65 (s, 1 H), 7.95-7.91 (m, 1 H), 7.88-7.80 (m, 2 H), 7.56-7.46 (m,
5 H), 4.71 (s, 1 H), 3.52-3.50 (br d, 4 H, J = 6 Hz); 13C NMR (DMSO-d6, δ): 182.6, 135.1, 134.6,
130.4, 128.8, 127.1, 126.8, 126.3, 125.6, 123.4, 59.9, 47.3. MS (ESI) ([M+H]+): 247.8, calcd for
C13H14N2OS 246.08.
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Dimethyaminoacetic Acid 2-(3-naphthalen-1-yl-thioureido)-ethyl Ester 4. To a solution of
N,N-dimethyl glycine (103 mg, 1 mmol) in 10 mL of CH2Cl2, 1,1'-carbonyldiimidazole (162 mg,
1 mmol) was added. The reaction mixture was stirred for 31/2 h at room temperature, then 1-(2hydroxy-ethyl)-3-naphthyl-thiourea (198 mg, 0.8 mmol) was added, and the reaction was stirred
for another 12 h at room temperature. The solvent was evaporated under reduced pressure, and
the residual solid was partitioned in chloroform/water. The organic layer was separated, and the
solvent was removed under reduced pressure.

The crude product was purified by column

chromatography (silica gel, CH3OH/EtOAc 3:97) to give pure monomer 4 as a white solid (67
mg, 0.202 mmol, 25%).

1

H NMR (300 MHz, DMSO-d6, δ): 9.74 (s, 1 H), 7.96-7.92 (m, 1 H),

7.87-7.81(m, 2 H), 7.57-7.41 (m, 5 H), 4.14 (t, 2 H, J = 5.6 Hz), 3.67 (td, 2 H, J = 5.5, 5.4 Hz),
3.09 (s, 2 H), 2.20 (s, 6 H);

13

C NMR (DMSO-d6, δ): 182.7, 170.8, 134.7, 130.5, 128.8, 127.6,

126.9, 126.9, 126.4, 125.9, 123.5, 62.6, 59.9, 45.2, 43.6. MS (ESI, high-resolution) ([M+H]+):
332.1408, calcd for C17H22N3O2S 332.1427.

2.3.3 Liposome Preparation for pH-Stat and Membrane Leakage Assay
Egg yolk L-α-phosphatidylcholine (EYPC ethanol solution, 60 μL, 79 μmol) was
dissolved in a CHCl3/MeOH mixture, the solution was evaporated under reduced pressure, and
the resulting thin film was dried under high vacuum for 2 h. The lipid film was hydrated for 40
min in 1.2 mL of sodium phosphate buffer (10 mM sodium phosphate, pH = 6.4, 100 mM NaCl,)
containing 100 μM pyranine. During hydration, the suspension was submitted to three freezethaw cycles (dry ice/acetone, water at room temperature). The resulting suspension of large
multilamellar vesicles (1 mL) was submitted to high-pressure extrusion at room temperature. As
judged by the dynamic light scattering analysis, 21 extrusions through a 0.1-μm polycarbonate
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membrane afforded a suspension of LUVs with an average diameter of 130 nm. The LUV
suspension was separated from the extravesicular dye by size-exclusion chromatography (SEC)
(stationary phase: Sephadex G-75, mobile phase: pyranine-free sodium phosphate buffer of the
same composition) and diluted with the same sodium phosphate buffer to give a stock solution
with a lipid concentration of 11 mM (assuming 100% of lipid was incorporated into liposomes).

2.3.4 Liposome Preparation for Endovesiculation Detection Assay

LUVs for the endovesiculation detection were prepared analogously to those for the
membrane leakage assay, except that the 100 mM HEPES/100 mM NaCl buffer (pH 7.1)
containing pyranine at 0-90 μM concentrations was used instead of PBS for lipid hydration and
the extrusion was carried out using 1 μm polycarbonate membrane. The dynamic light scattering
(DLS) analysis of the final LUV suspension revealed a 600 nm average diameter of liposomes.

2.3.5 pH-Stat Transport Assays
In a typical experiment, 100 μL of pyranine-loaded LUVs (stock solution) was suspended
in 1.9 mL of the symmetric pyranine-free buffer and placed into a thermostated
spectrophotometric cell. The suspension of liposomes was gently stirred throughout the entire
course of the experiment. The emission of pyranine at 510 nm was monitored with concurrent
excitation at 405 and 460 nm. The emission and excitation slits of the spectrophotometer were
set at 5 nm, time increments were set at 2 s, and the integration time was set at 0.5 s. The
temperature of the spectrophotometric cell was set at 25°C. During the experiment, 20 μL of a
0-100 μM DMSO solution of gramicidin or 0-500 μM aqueous solution of melittin was added
through the injection port, followed by injection of 21 μL of 0.5 M aqueous NaOH. Addition of
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NaOH resulted in a pH increase of approximately 1 pH unit in the extravesicular buffer, as
established by separate pH monitoring. Maximum possible changes in dye emission were
obtained at the end of each experiment by lysis of the liposomes with detergent (40 μL of 25%
aqueous Triton X-100).

The final transport trace was obtained as a ratio of the emission

intensities monitored at 460 and 405 nm and was normalized to 100% of transport.

2.3.6 Membrane Leakage Assays
The stock solution of the same LUVs as used in the pH-stat assays (100 μL) was
suspended in 1.9 mL of the symmetric pyranine-free buffer and placed into a thermostated
spectrophotometric cell. The instrumental settings were the same as in the pH-stat transport
experiments. The suspension of liposomes was gently stirred throughout the course of the
experiment. The emission of pyranine at 510 nm was monitored with excitation wavelength at
405 nm. During the experiment, 20 μL of a 0-1 mM solution of cyclen 1 in DMSO was injected
into the suspension of LUVs, followed by the injection of 20 μL of the same solution of
ionophore (gramicidin or melittin) as used in the pH-stat assays. The incubation time between
injections of cyclen 1 and peptide was 40 s. When necessary, the sequence of injections was
inverted, and the incubation time for the suspension of LUVs with peptide was increased up to
240 s.

Maximal possible changes in the dye emission were obtained at the end of each

experiment by lysis of LUVs with detergent (40 μL of 25% aqueous Triton X-100). The traces
were normalized to 100% of the emission change of pyranine.
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2.3.7 Microcalorimetric Titrations

The ITC titrations were carried out at 25°C using 1.423 mL of a methanolic solution of
titrated compound in the sample cell and the same amount of pure methanol in the reference cell.
In each experiment, a total of 40 injections of constant volume (7 μL) of the titrant solution was
made into the sample cell. The injections were separated by a lag time of 300 s. The heat
change associated with the dilution of titrant in the injection series was assessed from
independent experiments, where the titrant solution of the same concentration was injected into
the pure solvent. The integrated data were corrected by the amount of heat evolved from the
dilution of titrant, and the mole ratios were corrected by the dilution of components associated
with the volume change during an experiment.

2.3.8 Fluorometric Titration of Pyranine with Cyclen 1

The fluorometric titration of pyranine with cyclen 1 shown in Figure S4 in Appendix A.
In a typical experiment, an aqueous solution (2 mL) containing 50 nM pyranine, 100 mM NaCl,
and 10 mM NaxH3-xPO4 (x = 1,2; pH 6.4) was placed into a thermostated spectrophotometric cell
set at 25°C.

The solution was gently stirred during the experiment.

Prior to the

spectrophotometric recording, 20 μL of 0-500 μM solution of cyclen 1 in DMSO was added.
The emission spectra were recorded with the excitation wavelength 405 nm. The recording was
performed immediately after the addition of cyclen 1 and repeated after 30 min. Most of the
fluorescence loss occurred instantly upon the addition of cyclen 1.

No further change of

emission was observed at times longer than 30 min. For the accurate assessment of the binding
constant, the emission maxima at 510 nm recorded after a 30-min delay time were used for the
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binding isotherm fitting. Binding constant and the maximum emission loss with the confidence
interval values were computed using the homemade nonlinear regression curve-fitting program.
The 1:1 binding model was used.

2.3.9 Fluorometric Experiments with Control Compounds and Dyes

The titration of pyranine solutions with the control compounds was performed
analogously to that with cyclen 1, except that the concentrations of cyclen NH-Boc 3 and
monomer 4 in these experiments were varied in the range of 0-100 μM and the concentration of
cyclen 2 was varied in the range of 0-20 μM. The titration of PTA, APTS, ANTS, calcein, 5-CF,
6-CF, and safranin O with cyclen 1 was identical to that of pyranine. The control dyes were kept
at 50 nM concentration, whereas the concentration of cyclen 1 in the titration series was varied in
the range of 0-20 μM. Table S1 in Appendix A summarizes the instrumental settings for the
fluorometric monitoring of the dyes. No detectable change in the emission of calcein and 5-CF
was observed, whereas 9% fluorescence loss was observed for 6-CF in the presence of 20 μM
cyclen 1.

2.3.10 UV-Vis Titrations

The spectra of the dyes were recorded for the solutions in 1% of DMSO in PBS with 1%
DMSO in PBS used as blank. For the spectra of the dyes in the presence of cyclen 1, the
solution of cyclen 1 in 1% of DMSO in PBS was used as a blank.
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2.4 Results and Discussion
2.4.1 Design of the Receptor
We reasoned that a compound capable of selective binding of pyranine (Chart 2.2A) at
micromolar concentrations, impermeable to the bilayer membrane, and capable of quenching of
pyranine fluorescence would provide the basis for improved assays that do not rely on a high
concentration of pyranine quencher. The structure of pyranine comprises a planar pyrene core
and four peripheral anionic groups.

It has been reported that cyclen tetraesters bind

physiologically abundant Na+, forcing all four ester termini to come into close proximity.211, 212
We speculated that if two of these termini would hydrogen-bond to pyranine sulfonates and
phenolate and the two other termini would π–stack with pyranine’s aromatic core, we would
achieve a receptor for this dye. Additional stabilization of the complex is envisioned through the
electrostatic interactions of the protonated cyclen scaffold with anionic suflonates and the
phenolate of pyranine. Cyclen 1 satisfied these requirements and was synthesized via a four-step
procedure (Appendix 1). The schematic representation of the envisioned binding mode cyclen 1
and pyranine is shown on Chart 2.2B.
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representation of binding mode is solely speculative and is given for pictorial purposes only.
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2.4.2 Pyranine-Cyclen 1 Complex Characterization
The first indication of interaction between cyclen 1and pyranine dye was obtained from
the extraction experiments. When a chloroform-d (CDCl3) solution of cyclen 1 was treated with
an aqueous solution of pyranine, formation of precipitate was observed. Regardless of the
pyranine and cyclen 1 mole ratios, the minor component was always almost completely removed
from the solution phase upon extraction.

The precipitate formed was soluble in dimethyl

sulfoxide-d6 (DMSO), and the 1H NMR spectrum of this DMSO solution has shown signals
corresponding to pyranine and cyclen 1. The chemical shifts of pyranine and cyclen 1 signals in
DMSO were identical to those recorded for pyranine and cyclen 1 alone, suggesting that the
complex was destroyed by this solvent. The integral ratios for signals of two compounds were
independent of their mole ratios in the extraction series and corresponded to 1:1 complex
stoichiometry.
To gain more information on the thermodynamics of the complexation process, we
performed a series of isothermal titration calorimetry (ITC) experiments. The ITC experiments
require substantial solubility of interacting components in the common solvent, although
formation of a precipitate upon interaction is acceptable.213-215 Cyclen 1 has a very limited
solubility in water, therefore methanolic solutions were used instead. Both pyranine and cyclen
1 have a solubility of at least 15 mM in methanol which was suitable for ITC titrations. As with
the extraction experiments, the addition of a methanolic solution of pyranine to cyclen 1 resulted
in an extensive precipitate formation.
The formation of two distinct types of complexes was observed when a 10 mM solution
of cyclen 1 was titrated into a 0.25 mM solution of pyranine in an ITC experiment (Figure 2.1).
The assessed thermodynamic data for these complexes are summarized in Table 2.1.
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Figure 2.1: Microcalorimetric Characterization of Interactions of Cyclen 1 with Pyranine and
Calcein in Methanol: (A) Raw data for the titration of a 0.25 mM solution of pyranine with a 10
mM solution of cyclen 1. (B) Integrated data from (A), corrected by the heat of cyclen 1
dilution, normalized to moles of injectant and plotted as a function of cyclen 1/pyranine ratios
(solid squares). A continuous line represents the data fit in two sets of sites binding model. (C)
Raw data for the titration of a 0.25 mM solution of calcein with a 10 mM solution of cyclen 1.
Note the difference in vertical scales for plots (A) and (C). (D) Integrated data from (C),
corrected by the heat of cyclen 1 dilution, normalized to moles of injectant and plotted as a
function of cyclen 1/calcein ratios.

Table 2.1: Thermodynamic Parameters Assessed for the Complexation of Pyranine with Cyclen
1 in Methanola
Na
Ka(M-1)
ΔG (kcal/mol)
ΔH (kcal/mol)
TΔS (kcal/mol)
1.28 ± 0.014

(3.16 ± 0.75) × 106

−8.87 ± 0.17

−0.41 ± 0.05

8.47

3.57 ± 0.050

(1.46 ± 0.12) × 104

−5.68 ± 0.05

−3.87 ± 0.08

1.81

a

Number of binding sites for the individual complexation step obtained from the data fit to two sets of sites binding
model
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The first complex shows 1:1 stoichiometry, whereas the second complex corresponds to
the overall 1:4 pyranine/cyclen 1 stoichiometry. These two complexes have different affinities
and are driven by different thermodynamic forces. The originally formed 1:1 complex is 2
orders of magnitude stronger than the subsequently formed 1:4 complex. Whereas the formation
of the 1:4 complex is an enthalpically driven process, the 1:1 complex formation is almost
entirely an entropically driven process. The entropically driven 1:1 binding is consistent with the
solvophobic effect most likely accompanying π-π rather than hydrogen-bonding or electrostatic
interactions.216,

217

A much weaker 1:4 complex formation is a mostly enthalpically driven

process accompanied by a smaller positive entropy change. This second complexation step is
probably due to the electrostatic and/or hydrogen-bonding interactions of cyclen 1 molecules
with the initially formed 1:1 complex. Although the solvophobic effect plays a role in the 1:4
complex formation as well, the diminished entropy change likely stems from the decrease in the
degrees of freedom for the large aggregate formed from several molecules. Noteworthy, no
additional inflection points between 1:1 and 1:4 pyranine/cyclen 1 ratios were observed in the
ITC plot, suggesting that the second binding process proceeds via a concerted cooperative
mechanism.
1

H NMR analysis of the precipitate formed upon addition of an equimolar amount of

cyclen 1 to pyranine in methanol revealed that these two compounds produced a 1:1.5 mixture.
This ratio can be explained by the concurrent formation of a 1:1 complex (83%) and a 1:4
complex (17%). Clearly, the complexation of pyranine with cyclen 1 is a solvent-dependent
process: whereas 1:1 complexes were formed from both aqueous and methanolic solutions, the
enthalpically favored 1:4 complex was observed only for methanol, consistent with the fact that
electrostatic and hydrogen-bonding interactions are weakened in water compared to less-polar
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methanol.218-220 The fact that the complex between pyranine and cyclen 1 apparently does not
form in a polar but not self-associated solvent such as DMSO221-223 also supports the solvophobic
effect as a primary driving force for the complex formation. No apparent complex formation
between cyclen 1 and pyranine was observed in acetonitrile as well.
2.4.3 Evaluation of Cyclen 1 Affinity and Specificity to Pyranine under NearPhysiological Conditions
To be useful for kinetic biomembrane fluorometric assays, the pyranine receptor must (a)
have high affinity to the dye under physiological conditions; (b) be impermeable to the
membrane bilayer; (c) have fast kinetics of interaction with the dye; and (d) alter the
fluorescence of the dye significantly.
The solubility of cyclen 1 in aqueous medium is very limited, and even if the binding to
pyranine is strong, the capacity of cyclen 1 for binding with increasing amounts of the dye is
limited by its concentration in the solution. We detected the solubility limit for cyclen 1 in a
phosphate saline buffer (PBS, 100 mM NaCl, 10 mM Pi, pH=6.4) through a series of UV-vis
experiments where the absorbance of cyclen 1 solutions was plotted as a function of its
concentration (Figure S6, Appendix A). The saturation of absorbance was reached between 20
and 30 μM of cyclen 1 concentration. This concentration was ascribed to the limiting solubility
of cyclen 1 in PBS. At concentrations of 40 μM and above, precipitation was visually observed.
Titration of pyranine with cyclen 1 in PBS demonstrated an extensive loss of the dye
fluorescence (Figure S4, Appendix A). This loss was insensitive to the presence of Cl- and,
surprisingly, to Pi.224-226 The assessment of the binding constant gave an apparent value of (2.6 ±
0.3) x 106 M-1 (Table 2.2), meaning that low micromolar concentrations of cyclen 1 are
sufficient to quench pyranine emission. Interestingly, the Ka value assessed for the pyranine47

cyclen 1 complex in PBS from fluorometric titrations was very close to the Ka value determined
by ITC for the 1:1 complexation step in methanol. Although receptors for pyranine of lower 227
or comparable affinity are known,199, 228 to the best of our knowledge no fluorescence quenchers
for pyranine, active at such low concentration, have been reported to date. The affinity of cyclen
1 to pyranine in aqueous medium compares favorably to that of the other artificial receptors for
anionic

substrates.228-231

Importantly,

the

application

of

cyclen

1

to

egg

yolk

phosphatidylcholine (EYPC) LUVs loaded with 100 μM PBS solution of pyranine did not result
in a significant loss of pyranine fluorescence, showing that cyclen 1 is impermeable to the
bilayer membrane.

Table 2.2: Binding Constants and Maximal Fluorescence Loss Assessed for the Complexes of
Pyrene-Based Dyes and Cyclen 1 from Fluorometric Titration in PBSa
HPTS
PTA
APTS
HPTS-2b

a

Ka (M-1)

(2.6 ± 0.3) × 106

(2.1 ± 0.5) × 106

(7.7 ± 1.0) × 105

(9.2 ± 1.3) × 105

Imaxrel (%)

90.9 ± 1.6

103 ± 4.7

99.3 ± 2.8

96 ± 3.0

b

A 1:1 binding mode was assumed; Binding parameters assessed for pyranine−cyclen 2 complex.

The binding of pyranine to cyclen 1 in methanol and in the water/chloroform extraction
experiments at high (millimolar) concentrations was always associated with extensive complex
precipitation.

It was not clear whether the same precipitation is a leading cause of the

fluorescence disappearance at nanomolar concentrations of pyranine. To determine the reason
for this fluorescence loss, a parallel series of UV-vis and fluorometric experiments were
performed. A PBS solution containing 20 μM of pyranine and 20 μM cyclen 1 showed a
decrease in both pyranine absorbance at λmax = 406 nm and pyranine emission at 510 nm with
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excitation at 405 or 460 nm (Figure S5, Appendix A). This result was inconclusive, as the loss
of absorbance could be due to the complex precipitation or hypochromic shift induced by cyclen
1. However, when the concentration of pyranine and cyclen 1 were reduced to 2.67 and 10 μM
respectively, the fluorometric experiment still showed a loss of pyranine fluorescence, whereas
the UV-vis experiment showed an increase in pyranine absorbance accompanied by a modest
bathochromic shift (Figure 2.2).

This hyperchromic shift cannot be due to the complex

precipitation, and therefore it reflects the binding of cyclen 1 and pyranine in solution. We
concluded that the solubility product, Ksp, for the pyranine complex in PBS is higher than 2.67 x
10-11 and is lower than 4 x 10-10. The emission quenching observed in the fluorescence titration
series with pyranine at 50 nM and cyclen 1 at up to 10 μM concentrations therefore corresponds
to a concentration product of up to 5 x 10-13, which is below the solubility product for this
complex. We concluded that the fluorescence loss by pyranine in the titration experiments was
due to the formation of a water-soluble complex, but not to the complex precipitation.

A

B

A

B

Figure 2.2: UV−vis (A) and Fluorescence (B, ex = 405 nm) Spectra for Pyranine: (a) 2.67
μM solution of pyranine in 1% of DMSO in PBS. PBS with the same amount of DMSO
was used as a blank solution in UV−vis; (b) 2.67 μM pyranine, 10 μM cyclen 1 solution in
1% solution of DMSO in PBS. A 10 μM solution of cyclen 1 in 1% of DMSO in PBS was
used as a blank in UV−vis. The arrow directions show the change of the property upon
complexation.
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While the insolubility of a pyranine-cyclen 1 complex precluded its full structural
characterization, a series of control experiments demonstrated the importance of all elements
present in cyclen 1. Thus, neither cyclen tetra-NH-Boc 3 nor the monomer 4 affected pyranine
emission at concentrations up to 100 μM (Chart 2.2). These results suggest recognition of
pyranine rather than a simple electrostatic interaction of pyranine with cyclen 1, as well as the
importance of four binding arms in cyclen 1. With the solvophobic effect identified as a primary
driving force for the complexation of pyranine by cyclen 1, the cyclen tetraphenylthiourea 2 was
expected to show a weaker binding to pyranine. Indeed, the assessed Ka value (9.2 ± 1.3) x 105
M-1 for the cyclen 2-pyranine complex was 3 times smaller than that for the cyclen 1-pyranine
complex.
To show specificity of cyclen 1 toward the pyranine structure, the affinity of cyclen 1 to
several other dyes in PBS was evaluated. Four different categories of dyes were tested. The first
category combines the pyrene-based 1,3,6,8-tetrasulfonic acid (PTA) and 8-aminopyrene-1,3,6trisulfonic acid (APTS) with a topology similar to that of pyranine. The PTA molecule is
decorated with four sulfonic groups in place of substituents of pyranine, whereas the amino
group of the APTS molecule conceptually replaces the OH group of pyranine. The next category
was represented by 8-aminonaphthalene 1,3,6-trisulfonate (ANTS).

This dye features a

naphthalene core in place of pyranine’s pyrene and is decorated with the same periphery as the
APTS molecule. The third category of dyes combines anionic fluorescein-based dyes 5-CF, 6CF, and calcein. Whereas the electronic nature of the substituents in these dyes is similar to
those found in pyranine, the central cores of these dyes lack pyranine’s planarity and extended
conjugation.

Finally, the cationic dye safranin O was chosen as a negative control to

demonstrate that the fluorescence loss was not due to a nonspecific quench. The test of binding
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for these model dyes was performed using fluorescence, UV-vis, and microcalorimetry titrations.
The results of binding assays for selected dyes are summarized in Table 2.2.
Both APTS and PTA dyes produced complexes with cyclen 1 (Figure 2.3A). While the
Ka value for the PTA-cyclen 1 complex in PBS was almost identical to that of the pyraninecyclen 1 complex, a 3-fold drop in Ka value for the less-anionic APTS molecule was observed.
This drop demonstrates the importance of electrostatic interactions in the cyclen 1-pyranine
complex.

Figure 2.3: Fluorometric Titrations of Various Dyes with Cyclen 1: (A) Fluorometric
titrations of 50 nM PBS solutions of pyranine (triangles, ex 405 nm, em 510 nm), PTA
(squares, ex 376 nm, em 403 nm), and APTS (diamonds, ex 424 nm, em 503 nm) with
cyclen 1. Experimental data are normalized to the percentage of unbound dye
fluorescence. Continuous lines represent best fits to a 1:1 binding model. Note that the
three dyes show different extents of fluorescence loss upon binding to cyclen 1. Inset
shows the extent of complexation calculated for the data points from the main Figure 2.3A
as a function of cyclen 1 concentration. The point shapes denote the same dyes as in the
main Figure 3A. (B) Fluorometric titration of 50 nM ANTS (ex 365 nm, em 515 nm) with
cyclen 1 in PBS. No fitting to a binding model was attempted.
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The ANTS dye has demonstrated binding to cyclen 1 as well; however, the titration
results were drastically different from those for pyranine, PTA, or APTS dyes (Figure 2.3B).
While all three pyrene-based dyes gradually lost their fluorescence during the course of the
titrations, the fluorescence of ANTS dye initially increased and reached a 3-fold maximum of the
original fluorescence at the cyclen 1 concentration of 2.5 μM. Further increase of the cyclen 1
concentration resulted in a decrease of ANTS fluorescence, which reached its original value at a
cyclen 1 concentration of 20 μM. Clearly, such binding behavior cannot be described using a 1:1
binding model.232

Formation of bigger than 1:1 aggregates, complex precipitation, or the

combination of both can account for such complexation behavior. The observed fluorescence
loss of ANTS is not due to the increased optical density of the solution at the excitation
wavelength, as this optical density never exceeded the value of 0.05.154 Since the ANTS-cyclen
1 binding was not the main objective of the present study, no further attempt to clarify such
binding behavior was undertaken.
For the third category of dyes comprising fluorescein derivatives, no apparent binding by
cyclen 1 was detected at up to 20 μM concentrations by fluorometric and UV-vis titration
experiments. 6-CF lost 9% of its fluorescence in the presence of 20 uM cyclen 1. Some binding
of 6-CF to cyclen 1 is possible; however, low solubility of cyclen into a 1:1 isotherm within the
range of available cyclen 1 concentrations gave a value of 5 x 103 M-1 as a highest estimate for
the Ka of the 6-CF-cyclen 1 complex. For calcein, the most anionic dye within this category, the
possibility of binding was also tested by ITC in methanolic solution. These ITC experiments
revealed small, compared to pyranine, gradually decreasing negative enthalpy of interaction
without pronounced stoichiometric inflection points (Figure 2.1, parts C and D). This heat
emission can be well explained by protonation of the basic cyclen 1 by the acidic calcein. The
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apparent absence of binding for fluorescein derivatives demonstrates the crucial importance of
the planar conjugated core of the pyrene (and naphthalene)-based dyes for their recognition by
cyclen 1.
As expected, no binding of the cationic dye safranin O by cyclen 1 was detected by UVvis and fluorometric experiments.
2.4.4 Applicability of Cyclen 1 to Biomembrane Assays
To validate the applicability of cyclen 1 to the membrane leakage assay, we performed
experiments with the typical defect-forming peptide, melittin, and a typical ion channel forming
peptide, gramicidin.233,

234

As expected, the pH-stat experiments on pyranine-loaded LUVs

showed high, yet almost indistinguishable, activity of these peptides (Figure 2.4A).

The

application of these peptides to the same population of LUVs along with cyclen 1 clearly
revealed the difference in the two peptides’ mechanisms of action (Figure 2.4B). Whereas little
loss of pyranine emission was observed for gramicidin (trace a, pink line), a significant loss of
emission was observed for melittin (trace b, blue line) when cyclen 1 was applied to the
extravesicular buffer. A steady fluorescence quench observed in the presence of melittin reflects
the kinetics of pyranine release rather than the kinetics of cyclen 1-pyranine complexation.
Indeed, the experiment where melittin was injected first and cyclen 1 was added after 4 minutes
revealed a rapid quench of fluorescence, suggesting that most of the dye had been released by
that time (trace c, green line). Both traces b and c are almost identical at longer times, indicating
that the amount of released pyranine was independent of cyclen 1.
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Figure 2.4: Fluorescence Spectra of pH-stat and Membrane Leakage Assays: (A) pHstat assays in the absence of cyclen 1 performed on pyranine-loaded LUVs with 1 μM
gramicidin (a, blue trace) and 5 μM melittin (b, pink trace). I460/I405 was monitored as
function of time. (B) Membrane leakage assays performed on the same LUVs with
cyclen 1. I405 was monitored as function of time. Color code and time events: blue
trace (a) 10 μM cyclen 1 at 60 s, 1 μM gramicidin at 100 s; pink trace (b) 10 μM
cyclen 1 at 60 s, 5 μM melittin at 100 s; green trace (c) 5 μM melittin at 60 s, 10 μM
cyclen 1 at 300 s. Termination at 500 s: 0.5% Triton X-100.
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Unfortunately, cyclen 1 has found only limited applicability in the detection of
endovesiculation. Unlike with the membrane leakage assay, where all the dye was entrapped in
liposomes and any measurable change in fluorescence was sufficient for the event detection, the
endovesiculation detection required a fluorescence quench of large amounts of extravesicular
dye in the presence of small amounts of the dye entrapped in LUVs. Only the quenchers that
suppress the fluorescence of the dye completely can be utilized in this assay.

The high

concentration of DPX used in the currently employed endovesiculation detection assay is due to
the low affinity of DPX to pyranine. The assessed affinity of DPX to pyranine in PBS solution
gave a Ka value of (1.2 ± 0.2) x 103 M-1, which is three orders of magnitude lower than the Ka
value for the pyranine-cyclen 1 complex formed under identical conditions. However, the
ultimate quenching efficiency of DPX toward pyranine exceeds 99.7%,25 whereas the quenching
efficiency of cyclen 1 is not that high. Our titration experiments showed that the cyclen 1pyranine complex has an intrinsic fluorescence of approximately 9% of the fluorescence of
complex-free pyranine.
To increase the quenching efficiency of cyclen 1, we adopted a new protocol for the
detection of endovesiculation. Three sets of 600 nm EYPC LUVs containing 0, 20, and 90 μM
solutions of pyranine in 100 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid
(HEPES)/100 mM NaCl buffer (pH = 7.1), respectively, were prepared and suspended in a 90
μM solution of pyranine in HEPES buffer. These three sets were used to mimic 0, 22, and 100%
endovesiculation extent. A 20 μL aliquot of each population of liposomes was diluted with 2 mL
of pyranine-free HEPES buffer and treated with 20 μL of a 4 mM solution of cyclen 1 in DMSO.
Cyclen 1 was not fully soluble at this 40 μM concentration, and precipitate was formed.
However, there was an apparent interaction of pyranine at the surface of microcrystals formed by
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cyclen 1, resulting in more efficient removal of the dye from solution and fluorescence quench.
Because of the noise and fluorescence produced by the precipitated cyclen 1 – pyranine complex,
the solutions of LUVs were filtered through a cotton layer prior to the fluorometric experiments
(Figure 2.5).
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Figure 2.5: Emission Spectra for Three Sets of Liposomes Containing Different
Amounts of Pyranine: (A) Emission spectra (ex 405 nm) recorded for three sets of
liposomes containing 0, 20, and 90 μM solutions of pyranine and suspended in the
buffer containing 90 nM of pyranine. (B) Emission spectra for the same sets of
liposomes after the treatment with cyclen 1. The scale unit in (B) is the same as in (A).
Color code for the traces in both (A) and (B): pink (a) LUVs containing 90 μM
pyranine solution; blue (b) LUVs containing 20 μM pyranine solution; green (c) LUVs
containing no pyranine.

The emission spectra produced by these three sets of LUVs in the absence of cyclen 1
were almost indistinguishable due to the high extravesicular concentration of the dye (Figure
2.5A). The levels of the residual fluorescence for these sets of LUVs after the treatment with
cyclen 1 were different and qualitatively consistent with the amounts of the dye entrapped inside
(Figure 2.5B). LUVs containing no pyranine showed 3.1% fluorescence intensity in the absence
of cyclen 1. LUVs containing 20 and 90 μM solutions of pyranine showed 3.7% and 5.4%
original fluorescence intensity, respectively. These results were reproducible with the accuracy
of ±20% when the time between the addition of cyclen 1 and solution filtration was fixed at 5
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minutes. Longer incubations resulted in lower levels of fluorescence intensity, although the
relative values were close to those observed at 5 minutes of incubation.
Even with the advantage of low quencher concentration, this new endovesiculation
detection assay cannot replace the currently existing DPX-based assay for several reasons. First,
an additional filtration step is required, which lowers the accuracy of the results. Second, there is
a kinetic dependence of the fluorescence quench.
normalized after the filtration step.

Third, the results cannot be internally

In the DPX-based assay, the fluorescence extent is

normalized to the residual fluorescence observed after the lysis of LUVs by detergent. The
filtration step in a cyclen 1-based assay removes the quencher, and subsequent lysis does not
result in a fluorescence change, whereas the external normalization with the residual
fluorescence of pyranine-free LUVs lowers the accuracy of experiment. Finally, the incomplete
quench of the external pyranine emission drastically limits the sensitivity of the cyclen 1-based
assay. With all these disadvantages, the cyclen 1-based assay can still be used as a control to
remove the ambiguity imposed by a high concentration of the quencher in the DPX-based assay.
The limitations in applicability of cyclen 1 to biomembrane assays arose from its low
solubility and insufficient quenching efficiency. We plan to improve these characteristics in the
future by covalently attaching DPX and poly(ethylene glycol) (PEG) units to the cyclen-thiourea
core. These modifications should afford a pyranine receptor combining all features essential for
membrane assays, and this is the focus of our ongoing study.
In conclusion, we have rationally designed and synthesized a pyranine receptor cyclen 1.
Cyclen 1 revealed a high affinity to pyranine dye under near-physiological conditions. Utilizing
this affinity and the impermeability of cyclen 1 to the bilayer membrane, we have developed a
new membrane leakage assay that is fully compatible with the pH-stat assay. Applying the
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methods described herein, it becomes possible to distinguish between ion transport and
membrane leakage within a single set of experiments. We have also shown some limited
applicability of cyclen 1 to the detection of endovesiculation and we are currently working on the
synthesis of the pyranine-specific fluorescence quencher that is compatible with the
endovesiculation assay.
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Chapter 3

New Non-Invasive Methodology for Real-Time
Monitoring of Lipid Flip
This chapter was reproduced with permission from Bioconjugate Chem. 2007, 18, 1507-1515
from the American Chemical Society.
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3.1 Abstract
A new methodology for the detection of lipid flip was developed. This methodology
relies on the quenching of the fluorescence of the cascade-blue-labeled lipid through complex
formation with a membrane-impermeable cyclen-tetranaphthalenethiourea synthetic receptor for
this dye. The high affinity of the receptor to the cascade-blue label allows the use of micromolar
concentrations of this receptor during the experiment. At these low concentrations, the receptor
does not interfere with the membrane integrity and, therefore, renders this new methodology less
59

invasive to the model and cell membranes than commonly utilized 7-nitro-1,2,3-benzoxadiazol4-yl (NBD)-dithionite methodology.

Unlike with the NBD-dithionite assay, where the

fluorescence quenching of the NBD group is achieved through its chemical modification, this
new assay relies on the noncovalent interactions between cascade-blue label and the receptor.
Therefore, the quenching can be reversed by either competitive displacement of the lipidattached label with a water-soluble substrate, or by enzymatic degradation of the receptor leading
to the label release and fluorescence dequenching. We demonstrate that this new methodology is
suitable for the study of lipid flip in both model spherical bilayer membranes and in-vitro
experiments.
3.2 Introduction
Lipid flip detection assays allow monitoring of the activity of enzymes known as
flippases, floppases and scramblases77 and their fully synthetic80-83 or peptide analogues.84,

85

These enzymes control the transmembrane distribution of lipids in cells and are responsible for
membrane asymmetry.

Lipid translocation mediated by these enzymes is associated with

apoptosis64-68 and blood clotting.235,

236

Synthetic molecules capable of lipid flipping can be

considered as developmental therapeutics for several disorders,86, 87 such as Scott syndrome and
vascular complications in Alzheimer’s disease.88,

89

Furthermore, flip of cationic lipids may

greatly improve the efficiency of nonviral gene delivery systems.90 To date, three major assays
are utilized for the monitoring of lipid flip in model spherical bilayers (liposomes). The first
method relies on the flip of transferable fluorescent 7-nitro-1,2,3-benzoxadiazol-4-yl (NBD)labeled lipid from the donor liposomes to the acceptor liposomes containing nontransferable
rhodamine-labeled lipid that serves as a fluorescence quencher.164 The second methodology is
based on removal of the fluorescent lipid165 from the bilayer outer leaflet by incubation with
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serum albumin.166 The most conventional way for detection of flippase activity is based on the
irreversible quenching of the fluorescence of NBD-labeled lipids in cells167 or liposomes168, 169
with 10-60 mM sodium dithionite (Na2S2O4, Scheme 3.1A). The extent of lipid flip is assessed
from the residual fluorescence of liposomes after the application of the quencher. Because of its
anionic character, dithionite exhibits low permeability to the hydrophobic bilayer membrane and
therefore does not rapidly quench the fluorescence of the lipid located on the inner bilayer leaflet
but quickly quenches the fluorescence of lipid residing on the outer leaflet. The assay has
numerous intrinsic deficiencies arising from the high concentration of the quencher required for
the assay, the reductive nature of this reagent, and some permeability of the quencher to the
bilayer membrane. In addition, it has been shown recently that sodium dithionite diffusion
through the bilayer is similar or faster than that of unfacilitated lipid flip.170

Potentially,

dithionite can reduce the disulfide cross-links found in some flippases. For example, wild type
human P-glycoprotein, (Pgp), which is a known flippase,171 facilitates the lipid flip to a lesser
extent then Pgp treated with the reducing agent because of inhibitory disulfide cross-links
between nucleotide binding sites.172 In contrast, the activity of human scramblase protein is
suppressed by reducing reagents because of the reduction of disulfide cross-links.173 These
examples demonstrate that dithionite may affect the flipping activity of enzymes in a dual way
and, therefore, cannot be used in the real time monitoring experiments.
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Scheme 3.1: Schematic Representation of Lipid Flip Detection Assay and
Structures of the Compounds used in the Present Study: (A) Liposomes containing
fluorescently labeled lipids are treated with membrane-impermeable quencher.
Alterations in the residual fluorescence of the lipids from inner bilayer leaflet
serve as the measure of lipid flip. (B) Structures of the receptor 1 and
fluorescently labeled lipids used in the present study.
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3.3 Experimental Procedures
3.3.1 General
The 1H NMR spectra were recorded on a Varian AS400 instrument operating at 400.130
MHz or Varian Mercury instrument operating at 299.865 MHz. Chemical shifts are reported in
ppm relative to the residual protonated solvent peak. The mass spectra were recorded on a
Micromass Q-TOF™ 2 instrument (Manchester, UK) using the electrospray technique (positive
and negative modes were used). The samples were introduced into mass spectrometer using a
flow rate of 10 μL/min, the needle voltage was set at 3500 V with ion source at 110 oC, and the
cone voltage was set at 35 V. All spectrophotometric experiments were carried out on a
Fluoromax 3 (Jobin-Yvon/Horriba) spectrophotometer. The pH of solutions was monitored with
a Corning 350 pH/ion analyzer, using a Ag/AgCl pH-sensitive electrode (Accumet).
Chromatography was performed using 60-200 mesh silica purchased from Baker and 40-120 μm
Sephadex G-75 purchased from Aldrich.

Thin layer chromatography was performed on

Kieselgel 60 F254 and Uniplate™ Silica Gel GF silica-coated glass plates and visualized by UV
and I2. High-pressure extrusion was performed on the Avanti™ mini-extruder with a 0.1 μm
polycarbonate membrane. All chemicals, solvents and dyes were purchased from Aldrich,
Sigma,

Fluka

and

Invitrogen.

phosphatidylethanolamine

Egg

(DOPE),

glycero-3)-phosphoethanolamine

yolk

phosphatidylcholine,

L-alpha-dioleoyl

N-(7-nitro-2-1,3-benzoxadiazol-4-yl)-(1,2-dioleoyl-sn-

(NBD-PE)

and

N-(1-pyrenesulfonyl)-(1,2-dioleoyl-sn-

glycero)-3-phosphoethanolamine (lipid 6) were purchased from Avanti Polar Lipids.
3.3.2 Synthesis
Cyclen 1 was synthesized as previously reported.237
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Lipid 5 was synthesized in a one-step procedure as following: 1,2-dioleoyl-sn-glycero-3phosphoethanolamine (DOPE) (33 mg, 0.044 mmol) and 1-pyrenebutyric acid (68 mg, 0.177
mmol, 4-fold excess) were dissolved in 2 mL of dimethylformamide (DMF). A 1 mL solution of
N,N’-dicyclohexylcarbodiimide (DCC) (37 mg, 0.177 mmol, 4-fold excess) and 4dimethylaminopyridine (22 mg, 0.177 mmol, 4-fold excess) was added dropwise at 0◦C. The
reaction was allowed to come to room temperature and was stirred for 12 hours. The solution
was removed under reduced pressure and purified by column chromatography [silica gel,
gradient of chloroform (CHCl3) and methanol (MeOH)] yielding 9 mg of pure product (0.009
mmol, 20%). 1H NMR (CDCl3, δ): 8.18 (br s, 1H), 7.82-8.10 (m, 7H), 7.72 (br s, 1H), 5.28 (br
s, 4H), 4.34 (br s, 1H), 4.12 (br s, 2H), 4.02 (br s, 2H), 3.94 (br s, 2H), 3.50 (s, 8H), 3.28 (br s,
3H) 2.50-0.80 (br m, 59H).

MS (ESI, high-resolution) [M]-: 1012.5525 calculated for

C61H91NO9P- 1012.644.
Lipid 7 was synthesized in a two-step procedure:
i) 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (50 mg, 0.067 mmol) was dissolved in 5 mL
of methylene chloride (CH2Cl2), and diisopropylethylamine (20 μL, 0.115 mmol, 1.7-fold
excess) was added. A solution of bromoacetyl bromide (20 μL in 1 ml of CH2Cl2, 0.23
mmol, 3.4-fold excess) was added to the reaction mixture dropwise. The reaction mixture
was stirred for 12 hrs at room temperature, and the solvent and excess reagents were
removed under reduced pressure to afford crude N-(2-bromoacetyl)-1,2-dioleoyl-sn-glycero3-phosphoethanolamine. The crude product was purified by column chromatography (silica
gel, methanol:CH2Cl2 6:94) to give 53 mg of the pure product (0.061 mmol, 91%). 1H NMR
(CDCl3, δ): 10.36 (br s, 2H), 5.33 (app p, 2H, J = 2.4 Hz), 4.39 (br s, 1H), 4.13 (br s, 1H),
3.93 (br s, 2H), 3.79-3.65 (m, 4 H), 3.18-3.05 (m, 4H), 2.38-2.30 (m, 2H), 2.00 (app q, 4 H, J
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= 5.7 Hz), 1.73 (m, 2H), 1.65-1.15 (m, 48 H), 0.87 (app t, 6 H, J=5.7 Hz). MS (ESI, highresolution) [M]-: 862.5907, calcd for C43H78BrNO9P- 862.4598.
ii) N-(2-bromoacetyl)-1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (10 mg, 0.011 mmol)
was dissolved in 2 mL of acetone, potassium carbonate (10 mg, 0.072 mmol, 6.5-fold excess)
was added, and the reaction mixture was stirred for 40 min at room temperature. Then, 8hydroxypyrene-1,3,6-trisulfonic acid sodium salt (10 mg, 0.019 mmol, 1.7-fold excess) was
added, and the reaction mixture was stirred for 48 hours under reflux. The solvent was
evaporated under reduced pressure, and the residual solid was partitioned in chloroformwater.

The organic layer was separated, and the solvent was removed under reduced

pressure. The crude product was purified by the size exclusion chromatography (Sephadex
G-75 as solid phase, Millipore water as mobile phase) to afford 4 mg of pure lipid 7
(potassium salt, 0.0029 mmol, 26%). 1H NMR (CDCl3, δ): 7.70 (m, 1H), 7.51 (m, 1H), 7.10
(br s, 1H), 6.96 (br s, 1H); 6.82-6.73 (m, 2H), 5.37 (app s, 2H), 4.69 (app s, 1H), 4.38-4.33
(m, 4 H), 4.15 (br s, 2H), 3.89 (s, 1H), 3.62 (br s, 2H), 2.36-2.25 (m, 2H), 2.0 (m, 4H), 1.661.10 (m, 48H), 0.72 (app t, 6H, J= 5.7 Hz). (ESI,) [M]2-: 658.4895, calcd for
C59H85K2NO19PS32- 658.1948.
3.3.3 Preparation of Symmetric Liposomes for Lipid Flip Monitoring Assays
Egg yolk L-alpha-phosphatidylcholine (EYPC ethanol solution, 60 μL, 79 μmol) and
chloroform solution of labeled lipid (NBD-PE, lipid 5, 6 or 7, 20-50 μL, 79 nmol) were dissolved
in a CHCl3/MeOH mixture to give a 1:1000 mixture of labeled lipid:EYPC, the solution was
evaporated under reduced pressure, and the resulting thin film was dried under high vacuum for
2 h. The lipid film was hydrated for 40 min in 1.2 mL of sodium phosphate buffer (PBS), (10
mM sodium phosphate, pH = 6.4, 100 mM NaCl). During hydration, the suspension was
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submitted to 3 freeze-thaw cycles (dry ice/acetone, water at room temperature). The resulting
suspension of large multilamellar vesicles (1 mL) was submitted to high-pressure extrusion at
room temperature.

The large unilamellar vesicle (LUV) suspension was purified by size

exclusion chromatography (SEC) (stationary phase: Sephadex G-75, mobile phase: sodium
phosphate buffer of the same composition) and diluted with the same sodium phosphate buffer to
give a stock suspension with the total lipid concentration of 33 mM (assuming 100% of lipid was
incorporated into liposomes).
3.3.4 Preparation of Asymmetric Liposomes with Excess of Lipid 7 in the Outer Bilayer
Leaflet
The stock suspension of liposomes (30 μL), symmetrically labeled with lipid 7 (see
above) was diluted with 2 mL of phosphate buffer (10 mM sodium phosphate, pH = 6.4, 100
mM NaCl), and a solution of lipid 7 in DMSO (10 μL, 0-100 μM) was added. This suspension
was preincubated for 10 minutes prior the experiments. The immediate fluorescence monitoring
resulted in lower initial fluorescence levels, probably due to the slow incorporation of lipid 7 into
the liposomal exterior from the individual lipid 7-formed liposomes and self-quenching of the
lipid 7 fluorescence in these liposomes due to high local concentration of the cascade-blue
label.238
3.3.5 Kinetic Fluorescence Quenching Experiments with Symmetrically Labeled LUVs
In a typical experiment, 50 μL of LUVs labeled with lipid 5, 6, 7 or NBD-PE (stock
solution) was suspended in 1.95 mL of the phosphate saline buffer (10 mM sodium phosphate,
pH = 6.4, 100 mM NaCl) and placed into a thermostated spectrophotometric cell.

The

suspension of liposomes was gently stirred throughout the entire course of experiment. The
emission of labeled lipid (397 nm for lipids 5 and 6, 434 nm for lipid 7, and 534 nm for NBD66

PE) was monitored with the excitations at 317, 354, 402 and 460 nm respectively. The emission
and excitation slits of the spectrophotometer were set at 5 nm, time increments were set at 1 s,
and the integration time was set at 1 s. The temperature of the spectrophotometric cell was set at
25oC. During the experiment, 20 μL of a 0-5 mM DMSO solution of cyclen 1 or 1 M aqueous
solution of sodium dithionite was added through the injection port. At the end, the experiments
were terminated by the injection of 40 μL of 20% aqueous solution of Triton X-100. In the case
of experiments with variable amounts of Triton X-100, 40 μL injections of the corresponding
Triton X-100 aqueous solutions were performed. Binding constant and the maximum emission
loss with the confidence interval values were computed using a homemade nonlinear regression
curve-fitting program. The 1:1 binding model was used.
3.3.6 Kinetic Fluorescence Quenching Experiments with Asymmetrically Labeled LUVs
These experiments were carried out analogously to section 3.3.5, except that the
suspension of asymmetric LUVs described above were used without further dilution.
3.3.7 Cell Culture
HEK 293 cells were obtained from ATCC (Manassas, VA) and maintained at 37°C with
5% CO2 in an incubator. The culture medium used was minimum essential medium (MEM)
supplemented with 10% fetal bovine serum (FBS), 100 U/mL penicillin, and 100 g/mL
streptomycin (all from Invitrogen Corp, Carlsbad, CA). A2780 human ovarian carcinoma cells
were a generous gift from Dr. Stephen Williams, Ovarian Cancer Program, Fox Chase Cancer
Center, Philadelphia, PA. A2780 cells were cultured in Roswell Park Memorial Institute (RPMI)
(Gibco: Invitrogen, Carlsbad, CA) 5% FBS, 5% BCS (bovine calf serum), 0.25%
penicillin/streptomycin. Cells were routinely passaged at 80-90% confluency.

67

3.3.8 Confocal Imaging
The activity of the compounds tested was evaluated using confocal microscopy. HEK
293 cells were plated on 12-mm round glass cover slips pretreated with poly-D-lysine (BD
Biosciences, Bedford, MA). Prior to experiment, the cover slips with the cells were washed with
PBS, transferred to a small experimental chamber (Warner Instruments, Hamden, CT) mounted
on the stage of an Olympus confocal microscope (Olympus FV 300, Tokyo, Japan) equipped
with a x40/0.95 water immersion objective and cooled, charge-coupled device camera. The bath
solution contained (in mM): 140 NaCl, 3 KCl, 2 MgCl2, 25 D-glucose, 10 HEPES and 2 CaCl2,
with pH adjusted to 7.4 with NaOH (all from Sigma Aldrich (Atlanta, GA)). Cells were
visualized and selected for an experiment using the brightfield system. The excitation light to
the preparation was supplied from an LD-405 (Olympus) diode laser. The ultraviolet excitation
wavelength was controlled by a mirror unit that filtered the excitation at 360-370 nm and the
emission at 420-460 nm levels. Digital images (640x480 pixels) were obtained and processed
using Fluoview v.5.0 software (Olympus), and preset settings for DAPI (4,6-diamidino-2phenyl-indole) were used. Experiments were performed at room temperature (22-25oC). During
the experiment, 10 μL of 300 μM DMSO solution of lipid 5 or 7 was added to the bath solution
(1 mL), followed by the addition of 10 μL of 2.5 mM DMSO solution of cyclen 1.
3.3.9 Cell Growth Inhibition Assays
For the MTT (3-(4, 5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide) assay,
A2780 human ovarian carcinoma cells were plated at a density of 6,500 cells per well in a 96well plate and incubated overnight at 37°C in a 5 % CO2 atmosphere. Stock solutions of sodium
dithionite, 100 mM in media, and cyclen 1 compound, 5 mM in DMSO, were made fresh prior to
each use. Cells were treated at 10 mM and 25 M concentrations of sodium dithionite and
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cyclen 1, respectively, for 72 h. After medium removal, cells were washed twice with cold PBS
and incubated with MTT (2 mg/mL in PBS) for 3 h. The excess MTT (Sigma, St. Louis, MO)
was then removed, the dye dissolved in 100 μL of DMSO (Sigma, St. Louis, MO), and
absorbance was read on a Molecular Devices Vmax kinetic microplate reader at 540 nm.
Transmission images of the cells were obtained on an Olympus IX70 microscope, using 20x
magnification.
3.4 Results and Discussion
3.4.1 Identification of Appropriate Components for the Lipid Flip Detection Assay
We have recently developed a synthetic receptor, cyclen thiourea 1 (Scheme 3.1B),
which is capable of selective binding of anionic pyrene-based dyes with submicromolar affinity
under near physiological conditions.237 This receptor is impermeable to the bilayer membrane
and quenches 90-99% of the fluorescence of pyrene-based dyes. We hypothesized that this type
of receptor should be able to quench the fluorescence of the accessible portion of pyrene-labeled
phospholipids residing on the outer leaflet of the bilayer membrane of liposomes upon its
exogenous application. Such quenching of the fluorescence of the outer portion of the labeled
lipid should provide the basis for a new lipid flip detection assay. The high affinity of cyclen 1
to the anionic pyrene-based dyes should warrant the low micromolar concentration range
required for the fluorescence quenching and therefore provide less invasive conditions for the
lipid flip detection than in the otherwise analogous NBD-dithionite assay.
In order to verify the validity of such an approach we synthesized two pyrene-labeled
phospholipids (Scheme 3.1B): dioleoylphosphatidylethanolamine-pyrenebutyric acid 5 and
dioleoylphosphatidylethanolamine-hydroxypyrene

trisulfonate

7,

and

also

tested

the

commercially available dioleoylphosphatidylethanolamine-pyrene-sulfonamide 6. Previously,
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we identified the hydrophobic effect rather than electrostatic or hydrogen-bonding interactions as
the major driving force for the complex formation between pyrene-based dyes and cyclen 1.
Therefore it was reasonable to expect that neutral pyrene labels of phospholipids 5 and 6 will
also bind to cyclen 1.
Phospholipids 5 and 6 feature a neutral pyrene label tethered by linkers of variable
length. Phospholipid 5 was the most hydrophobic lipid among three probes because of nonpolar
nature of pyrene group and substantially higher hydrophobicity of amide linker than that of
sulfonamide linker of lipid 6.239 Therefore, lipid 5 was expected to diffuse across bilayer
membranes with the highest rate, whereas the trianionic character of the cascade-blue label240 in
the phospholipid 7 was expected to prevent any unmediated diffusion of this lipid across the
membrane.
First, we prepared three sets of large unilamellar liposomes (LUVs) from egg yolk
phosphatidylcholine (EYPC) containing 0.1 mol% of the pyrene-labeled lipids 5-7 evenly
distributed between the inner and outer leaflets of the bilayer. The emission spectra for the
suspensions of these three sets of liposomes were recorded in the presence (20 μM) and in the
absence of cyclen 1. No apparent changes in the fluorescent spectrum were observed upon
addition of cyclen 1 to the LUVs labeled with lipid 6. This is probably because the short length
of the linker connecting the pyrene label to the phospholipids caused the immersion of the
pyrene moiety into the hydrophobic region of the bilayer thus making this label inaccessible to
cyclen 1.
The identical experiments with LUVs containing phospholipids 5 and 7 revealed 46%
and 41% fluorescence intensity loss, respectively, upon addition of 20 μM cyclen 1 (Figure 3.1).
However, the kinetic experiments, where the maximum fluorescence intensity was monitored as
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a function of time, revealed that the fast loss of 46% of fluorescence by LUVs containing lipid 5
was followed by a somewhat slower phase of quenching resulting in the overall 80% loss of the
fluorescence in only 20 minutes (not shown). These results can be explained by the high rate of
unmediated diffusion of lipid 5 across the bilayer membrane and subsequent quenching of the
fluorescence of the exposed lipid by extravesicular cyclen 1. However, the secondary phase of
the fluorescence quenching in LUVs labeled with polar phospholipid 7 was negligibly slow,
consistent with the expected slow unmediated flipping rate for this lipid. The kinetic quenching
experiments were terminated by application of 0.5% of the detergent Triton X-100, which
resulted in a complete lysis of LUVs and exposure of the inaccessible portion of the fluorescent
lipids to cyclen 1.
Application of cyclen 1 to LUVs labeled with lipid 7 and lysis of these LUVs with the
detergent Triton X-100 gave 87% of fluorescence quenching. However, the fluorescence of the
LUVs labeled with lipid 5 increased upon application of Triton X-100 and even exceeded the
original fluorescence of the cyclen 1-free suspension of LUVs. This is most likely because of
repartitioning of nonpolar pyrene headgroup of lipid 5 into the hydrophobic core of the Triton X100 micelles, accompanied by the decomposition of the complex formed from lipid 5 and cyclen
1. This observation made lipid 5 a less attractive probe for lipid flip monitoring, and most of the
further work was carried out with the polar lipid 7.
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Figure 3.1: Fluorometric Characterization of Interactions of Cyclen 1 with
Fluorescently-Labeled LUVs: (A) Emission spectra (ex = 317 nm) of LUVs labeled
with lipid 5 in the absence (top spectrum) and in the presence (bottom spectrum) of 20
μM cyclen 1. (B) Emission spectra (ex = 402 nm) of LUVs labeled with lipid 7 in the
absence (top spectrum) and in the presence (bottom spectrum) of 20 μM cyclen 1.
LUVs in all experiments were suspended in 1% DMSO in the phosphate saline buffer.
3.4.2 Kinetic Experiments under Lipid Flip Mimicking Conditions
In order to find the optimal concentration of cyclen 1 required for the quenching of the
fluorescence of lipid 7, we carried out a series of kinetic titration experiments, where the
emission intensity of LUVs treated with variable amounts of cyclen 1 was monitored as a
function of time (Figure 3.2A). Application of variable amounts of cyclen 1 resulted in various
degrees of fluorescence quenching, however, the apparent saturation was observed at cyclen 1
concentrations above 10 μM.
The extent of fluorescence quenching by cyclen 1 can be interpreted in terms of complex
formation between lipid 7 and cyclen 1, therefore, the fluorescence data were fitted into the
binding isotherm (Figure 3.2B, 1:1 stoichiometry was assumed). The kinetics of fluorescence
quenching clearly consisted of two phases, where the primary fast phase was likely due to the
interactions of the outer leaflet portion of lipid 7, and the slower phase was due to the lipid
flipping from the inner leaflet into the outer leaflet, followed by complex formation. The
secondary phase was almost linear for all traces, therefore, linear fit of the data points in the
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secondary phase time interval (300-800 s for all traces) and extrapolation to the time of the
cyclen 1 injection (60 s in all traces) allowed us to assess the extent of lipid quenching in the
primary phase accurately. These data were fit into the binding isotherm, and the maximum
fluorescence quenching and apparent binding constant Ka were assessed. The found values for
these two parameters were 46±2% and 4.8(±1.5) x105 M-1, respectively. A similar data fit was
performed for the fluorescence intensity values after lysis of LUVs by Triton X-100. The
corresponding values for the maximum fluorescence quenching and binding constant Ka were
assessed as 92±4% and 2.1(±1.5) x 105 M-1, respectively. The maximum fluorescence quenching
by cyclen 1 before and after the lysis of liposomes is consistent with the hypothesis that the
membrane-impermeable receptor quenches 50% of the fluorescence in the symmetrically-labeled
LUVs, whereas the similar values of Ka before and after the lysis suggest that the detergent
produced little effect on the complex formation. The assessed binding constant for the lipid 7 –
cyclen 1 complex was approximately 10 times lower than that assessed for the complex of a
water-soluble dye 8-hydroxypyrene-1,3,6-trisulfonic acid (HPTS) reported previously,237
however, the affinity of cyclen 1 to the dye attached to the lipid remained high enough to allow
the detection of lipid flip with micromolar concentrations of cyclen 1.
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Figure 3.2: Kinetic Monitoring of the Fluorescence (ex = 402 nm, em = 434 nm) of LUVs
Labeled with Lipid 7 in the Presence of Cyclen 1: (A) Fluorescence of symmetrically-labeled
LUVs in the presence of variable amounts of cyclen 1. From top to bottom the traces at 500
s denote fluorescence of LUVs in the presence of 0 (green), 3.1(purple), 4.5(blue), 6.3(light
blue), 12.5(red), 25(golden) and 50 (pink) (μM) cyclen 1. Time events: 60 s: 20 μL of 0-5
mM DMSO solution of cyclen 1 was injected into 2 mL of LUVs suspension; 900 s: 40 μL of
aqueous 25% solution of Triton X-100 was injected. (B) Points in the upper trace (blue)
correspond to the fluorescence intensity values from (A) extrapolated to the maxima of the
fast quenching (see main text for explanation). Points in the bottom trace (pink) correspond
to the fluorescence intensity values after the lysis of LUVs with Triton X-100. Continuous
lines in both traces represent best fits to a 1:1 binding model. (C) Kinetic monitoring of the
fluorescence of LUVs asymmetrically labeled with lipid 7. From bottom to top at 30 s traces
denote LUVs containing 0.25 (dark blue), 0.31(golden), 0.38 (red), 0.5 (purple), 0.68 (sky
blue) and 0.75 (green) μM (bulk concentration) lipid 7 in the outer leaflet and 0.25 μM lipid
7 in the inner leaflet. Time events: 60 s: 20 μL of 2 mM DMSO solution of cyclen 1 was
injected into 2 mL of LUVs suspension; 900s: 40 μL of aqueous 25% solution of Triton X100 was injected. (D) Data from (C) after subtraction of the residual fluorescence and
normalization to 100% of the fluorescence of symmetrical LUVs.
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Next, we performed experiments with LUVs exhibiting asymmetry in the distribution of
the labeled lipid between the inner and outer bilayer leaflets. The residual fluorescence at the
end of experiments increased as the total concentration of cyclen 1–lipid 7 complex increased.
However, the ratio between fluorescence quenching upon application of 20 μM cyclen 1 and
fluorescence quenching upon application of Triton X-100 changed proportionally to the excess
of labeled lipid in the outer leaflet of the bilayer (Figure 3.2C). Subtraction of the residual
fluorescence and normalization of the fluorescence intensity to 100% of symmetrical LUVs gave
a set of traces with the extent of cyclen 1-induced fluorescence quenching proportional to the
amount of labeled lipid in the outer leaflet (Figure 3.2D). At the same time, the extent of
fluorescence quenching upon application of the detergent remained constant, consistent with the
unchanged amount of labeled lipid residing on the inner leaflet of the bilayer.

These

observations suggest that the proposed methodology is indeed suitable for the assessment of the
lipid distribution between the inner and outer leaflets of liposomal membranes.
In the envisioned mode of interaction between lipid 7 and cyclen 1, cyclen 1 binds to the
cascade-blue label of lipid 7 at the surface of the bilayer membrane. Therefore, it was possible
that the receptor bound to the membrane was perturbing the integrity of this membrane, thus
affecting the rate of the lipid flip. In order to find whether this was the case, we performed an
additional experiment with symmetrically labeled LUVs containing 0.5 mol % of lipid 7. This
five times higher concentration of lipid 7 would introduce five times more of cyclen 1 upon
binding. If cyclen 1 interferes with the integrity of the bilayer membrane, a different rate of lipid
7 quenching in the secondary slow phase would be observed.

However, the kinetic trace

obtained in the experiment with these new LUVs was identical (except the absolute fluorescence
intensity) to that obtained for the LUVs labeled with 0.1 mol % of lipid 7, including the extent of
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fluorescence quenching in the fast phase and the slope of the fluorescence quenching in the
secondary slow phase. Therefore, we concluded that cyclen 1 does not perturb the integrity of
the bilayer membrane in the range of concentrations of cascade-blue label used in these
experiments, and it does not affect the rate of the lipid flip.
3.4.3 Reversibility of Binding
The NBD-dithionite lipid flip assay relies on the irreversible covalent modification of the
NBD label by reduction of the nitro group to an amino group, which leads to the loss of
fluorescence. In contrast, the pyrene-cyclen 1-based assay relies on the noncovalent and,
therefore, potentially reversible interactions of the fluorescent label with the receptor. Two
independent methods can be considered for such binding reversal: first, a competitive
displacement of the fluorescent label, attached to the lipid with the water-soluble substrate for
the same receptor and, second, degradation of the receptor leading to the release of the
phospholipid label.
The first method has a disadvantage where all the identified substrates for the receptor
cyclen 1 are fluorescent dyes with spectral characteristics similar to that of cascade-blue label of
lipid 7. The largest spectral distinction, however, was found between the cascade-blue label of
lipid 7 (ex = 402 nm, em = 434 nm) and its synthetic precursor, HPTS (ex = 405 nm, em = 510
nm).

The displacement experiments, where a suspension of LUVs labeled with lipid 7 was

originally treated with 5 µM cyclen 1 and then with 0-10 µM HPTS, demonstrated an increase of
the fluorescence intensity at 434 nm (ex = 402 nm) upon addition of HPTS (Figure 3.3A). Yet,
a substantial contribution of the HPTS emission to the total intensity of the fluorescence at this
wavelength made this approach nonpractical.
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We are currently screening other potential

candidate molecules that might form strong complexes with cyclen 1 and displace cascade-blue
label of lipid 7.
To demonstrate the possibility for the second approach, we decided to enzymatically
degrade cyclen 1. The thiourea units of cyclen 1 are tethered to the cyclen scaffold via ester-type
linkers, making cyclen 1 a suitable substrate for a variety of esterases. In the course of the
kinetic experiment, the fluorescence of LUVs labeled with lipid 7 was monitored as a function of
time. The application of 10 µM cyclen 1 resulted in the loss of 43% fluorescence. Application
of 150 U of porcine liver esterase resulted in a gradual increase of the fluorescence, which
reached 90% of the original intensity in approximately 1.5 hours (Figure 3.3B). This example
demonstrates that the bound portion of lipid 7 can be released if required during the lipid flip
monitoring experiment.
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Figure 3.3: Reversibility of Cyclen 1-Lipid 7 Complexation: (A) Emission spectra of the
LUVs labeled with lipid 7 (ex = 402 nm): a) spectrum of LUVs in the presence of 1%
DMSO (blank experiment); b) spectrum of LUVs in the presence of 5 μM cyclen 1 and 1%
DMSO; c) spectrum of LUVs in the presence of 5 μM cyclen 1, 1% DMSO and 5 μM
HPTS. The intensities were normalized to 100% of the emission intensity of cyclen 1-free
set of LUVs (trace a) at 434 nm. (B) Kinetic monitoring of the fluorescence intensity of
LUVs labeled with lipid 7 upon application of 10 μM cyclen 1, followed by the application
of porcine liver esterase (150 U).
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3.4.4 Comparative Invasiveness of Cyclen 1 and Sodium Dithionite
Another potential disadvantage of the NBD-dithionite assay can arise from the fact that
dithionite is the anion of inorganic salt and can therefore be taken up by cellular transporters, for
example sulfate-anion exchangers.241

Such internalization of dithionite would result in the

reduction of the NBD-label residing on the inner leaflet of the bilayer and may lead to the falsepositives in the in vitro experiments. A large molecule of cyclen 1 will unlikely be a substrate
for cellular transporters; therefore, no such false positive identification of lipid flip activity
should be expected. We demonstrated this potential advantage of cyclen 1-based assay in an
experiment with LUVs under ion-transport mimicking conditions.

It has been shown that

detergents at sublytic (below CMC) concentrations form transient pores in the bilayer
membranes that may allow passage of small molecules.242-244

Specifically, sublytic

concentrations of Triton X-100 were shown to increase permeability of erythrocyte membranes
to small ions (Na+, Cl-) but not to the relatively large molecules (glucose).245 We performed a
parallel series of kinetic experiments with LUVs containing NBD-labeled phospholipid and
LUVs labeled with lipid 7 (Figure 3.4). The slope of the secondary quenching phase was
substantially higher for the LUVs labeled with NBD-PE than with lipid 7. This is probably
because of a higher rate of unmediated transmembrane diffusion of sodium dithionite than that of
cyclen 1 at their operating concentrations. As can be seen, the fluorescence decay upon injection
of Triton X-100 to LUVs labeled with lipid 7 and treated with 20 μM cyclen 1 was observed
only at Triton X-100 concentration exceeding CMC (0.22 mM).246

However, in similar

experiments with NBD-labeled LUVs, treated with 60 mM Na2S2O4, a substantial decrease in the
fluorescence was observed after application of submicellar concentrations of the detergent.
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Figure 3.4: Comparison of NBD-Dithionite and Cyclen 1-Lipid 7 Lipid Flip Monitoring
Assay in the Presence of Variable Amounts of Triton X-100: (A) Kinetic monitoring of
the fluorescence of NBD-labeled LUVs treated with 60 mM Na2S2O4 and varying
amounts of Triton X-100. From top to bottom the traces at 1500 s denote application of
0.12, 0.17, 0.22, 0.36, 0.72, 1.45 and 2.9 (mM) Triton X-100. Please, note a significant
fluorescence quenching at 0.17 mM (below CMC) concentration of Triton X-100 (second
trace from top). (B) Kinetic monitoring of the fluorescence of lipid 7-labeled LUVs
treated with 20 μM cyclen 1 and varying amounts of Triton X-100. From top to bottom
the traces at 400 s denote 0.12, 0.22, 0.36, 0.72, 1.45, 2.9 (mM) Triton X-100. Please
note that the application of submicellar and micellar concentrations of Triton X-100 (two
upper traces) resulted in a little loss of the fluorescence quenching. In both figures, the
traces were normalized by the subtraction of the residual fluorescence observed in the
sample with highest amount of Triton X-100, and adjustment to 100% of the initial
fluorescence values.
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3.4.5 Physiological Compatibility of Cyclen 1
To demonstrate the relative nontoxicity of cyclen 1, a series of cell growth inhibition
assays were performed in the presence of cyclen 1 and sodium dithionite at concentrations
relevant to the lipid flip monitoring assays.
These assays revealed 10% inhibition of cell growth in the presence of 25 μM cyclen 1,
compared to untreated cells, and approximately 5% cell growth inhibition compared to the cells
treated with relevant amounts of DMSO (0.5%), consistent with physiological compatibility of
this receptor (Figure 3.5A). Treatment of the cells with the smallest concentration of sodium
dithionite used in the lipid flip monitoring assays (10 mM) resulted in 15% growth inhibition.
No morphological signs of cell damage or death was observed upon treatment with cyclen 1
(Figure 3.5B).
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Figure 3.5: Relative Non-Toxicity of Cyclen 1: (A) Results of growth inhibition
assay (A2780 cell line) relative to untreated cells. (B) Images of A2780 cells
from the growth inhibition assays: a) untreated cells, b) cells in the presence of
0.5% DMSO; c) cells in the presence of 25 μM cyclen 1 and 0.5%DMSO.
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3.4.6 Applicability of New Methodology to the in Vitro Studies
Finally, we demonstrated that the cyclen 1-based lipid flip monitoring assay can be
utilized for in vitro studies. We ran a series of confocal microscopy imaging experiments on
HEK-293 cells. These showed that the application of lipid 7 resulted in its rapid partitioning into
the plasma membranes of the cells (Figure 3.6A-C). Immediate application of cyclen 1 (20 μM)
resulted in a complete fluorescence quenching consistent with the fact that all lipid 7 was
accessible to the receptor. However, the incubation of the cells with lipid 7 for 1 hour resulted in
partial diffusion of lipid 7 into the internal membranes of cellular organelles. Application of 20
μM cyclen 1 in this case resulted in the fluorescence quenching of the outer cell membranes, but
some residual fluorescence of the cell interior was still observed (Figure 3.6D-H). Finally, we
performed staining of the cells with lipid 5, which has high permeability to the membrane
barriers (Figure 3.6I-O). Unlike with lipid 7, no preferential staining of the outer membranes
was observed but rather even distribution of the fluorescent lipid within the cellular interior. A
subsequent application of cyclen 1 resulted in the fluorescence quenching, which was complete
after 15 minutes of incubation.
These experiments demonstrate that a lipid 7-cyclen 1 pair provide a suitable pair for the
lipid flip monitoring in in vitro experiments. The focus of our future studies will be a real-time
monitoring of the flippase activity of Pgp, using a lipid 7-cyclen 1 lipid flip monitoring assay.
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Figure 3.6: Confocal Microscopy Images of HEK-293 Cell Clusters (Caption on following page.)
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Figure 3.6: Confocal Microscopy Images of HEK-293 Cell Clusters:
Images A-C, D-H and I-O correspond to three distinct sets of cell clusters.
(A) Brightfield image of the first set of cell clusters. Consequent fluorescence
images of the first set of clusters immediately after addition of lipid 7 (B) and upon
addition of the quencher cyclen 1 (C) (the time interval between additions of lipid 7
and cyclen 1 was less than 5 minutes).
(D) Brightfield image of the second set of cell clusters. Consequent fluorescence
images of the second set of clusters immediately after addition of the lipid 7 (E), after
one hour of incubation with the lipid 7 (F), immediately (G) and 20 minutes (H) after
the addition of the quencher cyclen 1.
(I) Brightfield image of the third set of cell clusters. Consequent fluorescence images
of the third set of clusters immediately after the addition of lipid 5 (J), after 30
minutes (K) and one hour (L) incubation with the lipid 5; immediately (M), 10
minutes (N) and 20 minutes (O) after the addition of the quencher cyclen 1.
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As with any other fluorometric methodology, the interpretation of the results obtained
through the lipid 7-cyclen 1 lipid flip detection assay requires some care because of the possible
effects of the non-natural cascade-blue label attached to the lipid molecule. However, the highly
anionic character of the cascade-blue label makes a flip of such conjugated lipids more difficult
than that of the less polar natural lipids, and therefore no false-positive flippase activity should
be detectable by this new methodology. As an alternative, the hydrophobic lipid 5 in place of
lipid 7 can be utilized, although with some limitations, to test the flip of less polar substrates.
3.5 Conclusion
In conclusion, we developed a new methodology for monitoring of lipid flip in both
model and cell membranes. This methodology relies on the micromolar concentrations of the
fluorescence quencher cyclen 1 and therefore has better compatibility with the physiological
conditions than the commonly utilized NBD-dithionite methodology which relies on high
millimolar concentrations of sodium dithionite. Unlike with NBD-dithionite assay, where the
dithionite causes the irreversible quenching of the fluorescence of NBD-labeled lipid, cyclen 1
forms a noncovalent complex with cascade-blue labeled lipid. The noncovalent nature of such
interactions provides a possibility for the reversal of binding through the displacement of the
cascade-blue labeled lipid by a water-soluble substrate for cyclen 1. Alternatively, the complex
between cyclen 1 and lipid 7 can be decomposed through the enzymatic degradation of cyclen 1.
The focus of our future studies will be a real-time monitoring of the flippase activity of Pgp,
using a lipid 7-cyclen 1 lipid flip monitoring assay.
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4.1 Abstract
New pH-sensitive lipids were synthesized and utilized in formulations of liposomes
suitable for controlled drug release. These liposomes contain various amounts of NaCl in the
internal aqueous compartments. The release of the drug model is triggered by the application of
an HCl co-transporter in exogenous physiologically relevant NaCl solution.

The HCl co-

transporter allows the uptake of HCl by liposomes to an extent that is proportional to the
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transmembrane Cl- gradient. Therefore, each set of liposomes undergoes internal acidification,
which ultimately leads to the hydrolysis of the pH-sensitive lipids and release of contents at the
desired time. The developed system releases the drug model in a stepwise fashion with the
release stages separated by periods of low activity. These liposomes were found to be insensitive
to physiological concentrations of human serum albumin and to be non-toxic to cells at
concentrations exceeding pharmacological relevance. These results render this new drug release
model potentially suitable for in vivo applications.
4.2 Introduction
Biocompatible, pH-sensitive liposomes have recently become attractive vehicles for
intracellular drug247, 248 and gene delivery.249-253 Targeted delivery of pH-sensitive liposomes to
tumors, or infected sites with increased acidity was also proven successful.254,

255

Whereas

reports on the applications of pH-sensitive liposomes for the intracellular delivery of therapeutic
components are quite numerous, there are only few reports on the applicability of pH-sensitive
liposomes for controlled drug release.256-259 The lack of applications for pH-sensitive liposomes
for controlled drug release in blood plasma is due to the narrow range of intravascular pH, which
is largely maintained by carbonic anhydrase.260

All literature precedence concerning pH

sensitive liposomes reports a release of contents via an exogenous change in pH; and, to the best
of our knowledge, a release of contents due to an internal liposome acidification has yet to be
reported. The internal acidification of liposomes, triggered by contact with blood plasma or
other physiological fluid, provides a new model of a controlled drug release system, suitable for
therapy of diseases such as diabetes.261
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In this paper, we report on the development of a new drug delivery system that provides a
release of the drug model through a series of burst-like events. The system is based upon the
mixture of several sets of liposomes containing pH-sensitive lipids 8 or 9 in the bilayer
membrane and various amounts of NaCl in the internal buffers. The release of contents of
liposomes is triggered by contact with phosphate buffer saline (PBS) and/or application of HCl
co-transporter 10 (Scheme 4.1).262

N

Scheme 4.1: Compounds Utilized in the Present Study: 8 and 9: pH-sensitive
synthetic lipids. 10: HCl-cotransporter triphenoxyacetamide. Cyclen 1: Synthetic
receptor for HPTS dye.
The HCl co-transporter 10 delivers HCl into the internal aqueous compartments of
liposomes, making them more acidic. Since the induced pH change is a function of the Clgradient, formulating liposomes with a preset internal NaCl concentration allows their future
acidification to specific levels, ultimately causing a kinetically controlled decay of acetals 8 or 9;
with the decay occurring fastest in the most acidic liposomes (Scheme 4.2). The acetal-bearing
molecules have previously been used in pH-sensitive drug delivery vehicles, and the kinetics of
their hydrolysis makes them suitable for the controlled contents release.263-265
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Scheme 4.2: Stepwise Release of Liposome Contents Triggered by a Single Application
of HCl Co-Transporter 10: Depending on the amounts of internal NaCl, liposomes are
acidified by the action of 10 to variable extents and then release their contents upon
hydrolysis at different times.
4.3 Materials and Methods
4.3.1 General
The 1H NMR spectra were recorded on a Varian AS400 instrument operating at 400.130
MHz or Varian Mercury instrument operating at 299.865 MHz. Chemical shifts are reported in
ppm relative to the residual protonated solvent peak. The 13C NMR spectra were recorded on the
same instruments at 100.613 MHz and 75.408 MHz respectively and chemical shift values are
reported in ppm relative to the solvent peak. Both 1H and

13

C spectra were taken in the same

solvent and on the same instrument for each sample. The low resolution mass spectra were
recorded on a Micromass Q-TOF™ 2 instrument (Manchester, UK) using the electrospray
technique (positive mode). The samples were introduced into mass spectrometer using a flow
rate of 10 μL/min, the needle voltage was set at 3500 V with ion source at 110°C and the cone
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voltage at 35 V. The high resolution mass spectra were recorded on a LCMS-IT-TOF (Shimadzu
Corporation, Columbia MD) instrument using the electrospray technique (positive mode). All
spectrophotometric experiments were carried out on a Fluoromax 3 (Jobin-Yvon/Horriba)
spectrophotometer. The dynamic light scattering analysis of the liposome suspensions was
carried out on the Malvern instrument (Malvern Zetasizer Nano Series, Malvern Instruments).
The pH of solutions was monitored with a Corning 350 pH/ion analyzer, using a Ag/AgCl pHsensitive electrode (Accumet).

Chromatography was performed using 60-200 mesh silica

purchased from Baker and 40-120 μm Sephadex G-75 purchased from Aldrich. Thin layer
chromatography was performed on Kieselgel 60 F254 and Uniplate™ Silica Gel GF silica-coated
glass plates and visualized by I2. High-pressure extrusion was performed on the Avanti™ miniextruder with a 0.1 μm polycarbonate membrane. All chemicals and solvents were purchased
from Aldrich, Sigma or Fluka. Phospholipids were purchased from Avanti Polar Lipids.
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4.3.2 Synthesis
Synthesis of pH-sensitive lipids 8 and 9 is outlined in Scheme 4.3.

Scheme 4.3: Synthesis of Lipids 8 and 9: (8: R = C16H33, 9: R = Z-C8H16CH=CHC8H17) i) TosOH, hexadecanol or oleoyl alcohol, THF; ii) 2-(dimethylamino)
ethanol, NaH, THF; iii) ethyl bromoacetate, diethyl ether; iv) aqueous KOH,
MeOH:THF.

1-(2-bromo-1-(hexadecyloxy)ethoxy)hexadecane 8a. To a solution of p-toluenesulfonic acidmonohydrate (440 mg, 2.58 mmol) in acetone (200 mL) was added a small amount of Na2SO4.
The resulting solution mixture stirred at room temperature for 30 minutes and was subsequently
filtered to remove remaining Na2SO4. The solvent of the filtrate was removed under diminished
pressure affording a white residue. The white residue was mixed with anhydrous THF (25 mL)
and transferred to an addition funnel containing bromoacetaldehyde-diethyl acetal (5.0 g, 0.0258
mol) in anhydrous THF (100 mL). The resulting solution mixture was added dropwise over 45
minutes to hexadecanol (61.9 g, 0.255 mol), under N2 at 65°C. The reaction mixture was stirred
at reflux (68.8°C) for 3 days. Then, the reaction mixture was cooled to room temperature and the
solvent was removed under reduced pressure. The residue was extracted with hexanes (250 mL)
and cooled in an ice bath (0°C) to crystallize out any unreacted hexadecanol, which was filtered
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off. The remaining organic filtrate was washed with saturated sodium bicarbonate and brine.
The organic portions were combined, dried over MgSO4 and concentrated under diminished
pressure producing an orange solid.

The crude solid was purified via flash column

chromatography (silica gel, 20% CHCl3/Hexanes) affording a white solid (2.009 g, 0.0258 mol,
13%). 1H NMR (300 MHz, CDCl3) δ 4.16 (td, J = 6.7, 0.8 Hz, 1H), 3.60 (d, 2H), 3.37 (t, 4H),
1.65 (dd, J = 14.2, 6.9 Hz, 2H), 1.54 (s, 4H), 1.26 (s, 50H), 0.88 (t, J = 6.7 Hz, 6H).

13

C NMR

(400 MHz, CDCl3) δ 101.67, 67.18, 32.16, 29.93, 29.60, 26.34, 22.93, 14.35. MS (ESI, highresolution) ([M+Na]): 613.3284, calcd for C34H69BrNaO2 m/z: 613.44.

2-(2,2-bis(hexadecyloxy)ethoxy)-N,N-dimethylethanamine 8b.

NaH (60% in mineral oil,

0.284 g, 0.0118 mol) was carefully mixed with hexanes (100 mL, deoxygenated) at room
temperature to separate NaH from mineral oil. After NaH settled, hexanes were removed by
gravity filtration. Anhydrous THF (20 mL) was added to the NaH and the resulting solution
mixture was cooled to 0°C. A solution of 2-(dimethylamino) ethanol (0.26 mL, 0.0258 mol) was
added dropwise to the NaH solution. The resulting solution stirred at 0°C under N2 for 30
minutes.

The solution was warmed to room temperature and heated to reflux (70°C).

Compound 8a (0.503 g, 0.852 mmol) in anhydrous THF (50 mL) was then added. The resulting
reaction mixture stirred at reflux (70°C) for 3 days. The reaction mixture was slowly cooled to
room temperature and subsequently cooled to 0°C. A dropwise addition of H2O, to quench any
remaining NaH, was continued until gas evolution ceased. The reaction mixture was extracted
with hexanes, washed with brine and concentrated under diminished pressure producing a yellow
oil. The crude oil was purified via flash column chromatography (silica gel, 7% MeOH/CHCl 3 –
20% MeOH/CHCl3) affording a yellow oil (0.031 g, 6%). 1H NMR (300 MHz, CDCl3) δ 4.61 (t,
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J = 5.2 Hz, 1H), 3.90 – 3.21 (m, 8H), 2.57 – 2.41 (m, 2H), 2.27 (s, 6H), 1.65 (dd, J = 14.2, 6.9
Hz, 2H), 1.54 (s, 4H), 1.26 (s, 50H), 0.88 (t, J = 6.7 Hz, 6H).

13

C NMR (75 MHz, CDCl3) δ

101.66, 71.85, 69.85, 67.14, 58.94, 45.97, 32.42, 32.15, 30.59, 29.84, 29.15, 26.50, 22.91, 14.33.
MS (ESI, high-resolution) ([M+1]+): 598.6648, calcd for [C38H79NO3]+ m/z: 598.61.

N-(2-(2,2-bis(hexadecyloxy)ethoxy)ethyl)-2-ethoxy-N,N-dimethyl-2-oxoethanaminium

8c.

To a solution of 8b (0.015g, 0.0251 mmol) in diethyl ether (4.0 mL) was added
ethylbromoacetate (0.040 g, 0.240 mmol). The reaction mixture was stirred at room temperature
for 19.5 hours. The crude reaction solution was concentrated under diminished pressure. The
crude residue was purified via column chromatography (silica gel, 10 % MeOH/CHCl3)
affording a white solid (0.012g, 0.0082 mmol, 71%).

1

H NMR (300 MHz, CDCl3) δ 4.85 (s,

2H), 4.54 (t, J = 4.7 Hz, 1H), 4.22 (dt, J = 10.8, 5.8 Hz, 4H), 3.99 (d, J = 4.3 Hz, 2H), 3.70 (s,
6H), 3.64 – 3.24 (m, 4H), 1.70 (d, J = 18.4 Hz, 4H), 1.58 – 1.39 (m, 4H), 1.39 – 1.21 (m, 50H),
1.00 (dd, J = 6.7, 3.6 Hz, 3H), 0.87 (t, J = 6.7 Hz, 6H).

13

C NMR (75 MHz, CDCl3) δ 164.99,

101.66, 71.85, 69.85, 67.14, 58.94, 45.97, 36.32, 32.42, 32.15, 30.59, 29.84, 29.15, 26.50, 22.91,
14.33. MS (ESI, high-resolution) ([M]+): 684.4030, calcd for [C42H86NO5]+ m/z: 684.65.

2-((2-(2,2-bis(hexadecyloxy)ethoxy)ethyl)dimethylammonio) acetate 8. A solution of KOH
(0.8 mg, 0.0146 mmol) in H2O (0.3 mL) was added to a solution of 8c (0.002 g, 0.00292 mmol)
in THF:MeOH (1:1, 1.0 mL). The resulting reaction mixture was stirred at room temperature for
15 minutes, then the solution was concentrated under reduced pressure. The crude material was
mixed with CH2Cl2 (2.0 mL) and then subsequently washed with H2O (2.0 mL). The organic
layer was concentrated under reduced pressure to give a white solid (1.8 mg, 0.00274 mmol,
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95%). 1H NMR (300 MHz, CDCl3) δ 4.52 (m, 1H), 3.89 (d, J = 18.5 Hz, 2H), 3.75 – 3.26 (m,
14H), 1.76 (m, 4H), 1.76 – 0.73 (m, 54H), 1.04 – 0.73 (m, 6H).

13

C NMR (75 MHz, CDCl3) δ

165.06, 101.02, 71.48, 67.26, 66.05, 63.24, 53.32, 32.15, 30.68, 29.46, 26.39, 22.92, 14.35. MS
(ESI, high-resolution) ([M+H]+): 656.4811, calcd for [C40H82NO5]+ m/z: 656.62.
(Z)-1-(2-bromo-1-((Z)-octadec-9-en-1-yloxy)ethoxy))octadec-9-ene 9a. To a solution of ptoluenesulfonic acid-monohydrate (476 mg, 2.5 mmol) in acetone (200 mL) a small amount of
Na2SO4 was added. The resulting mixture was stirred at room temperature for 30 minutes and
was subsequently filtered to remove Na2SO4. The solvent of the filtrate was removed under
diminished pressure affording a white residue. The white residue was mixed with anhydrous
THF (25 mL) and transferred to an addition funnel containing bromoacetaldehyde-diethyl acetal
(3.0 g, 0.015 mol) in anhydrous THF (100 mL). The resulting solution mixture was added
dropwise over 45 minutes to oleyl alcohol (4.0 g, 0.15 mol), under N2 at 65°C. The reaction
mixture was stirred at reflux (68.8°C) for 3 days. Then the reaction mixture was cooled to room
temperature and the solvent was removed under reduced pressure. The residue was extracted
with hexanes (250 mL), washed with saturated sodium bicarbonate and brine. The organic
portions were combined, dried over MgSO4 and concentrated under reduced pressure producing
an orange colored oil. The crude oil was purified via column chromatography (silica gel, 20%
CHCl3/Hexanes – 50% CHCl3/Hexanes) affording a lemon colored oil (7.26 g, 0.011 mol, 75%).
1

H NMR (400 MHz, CDCl3) δ 5.51 – 5.28 (m, 4H), 4.65 (t, J = 5.4 Hz, 1H), 3.72 – 3.43 (m, 4H),

3.38 (t, J = 9.8 Hz, 2H), 1.99 (dd, J = 13.3, 6.7 Hz, 8H), 1.58 (dd, J = 14.5, 6.8 Hz, 6H), 1.25
(dd, J = 21.7, 9.4 Hz, 42H), 0.88 (t, J = 6.8 Hz, 6H);

13

C NMR (300 MHz, CDCl3) δ 130.07,

101.31, 66.67, 32.35, 31.57, 30.22 , 28.42, 26.94, 25.94, 22.43, 13.87. MS (ESI, high-resolution)
([M+Na]+): 663.4293, calcd for C38H73BrNaO2 m/z: 663.47.
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2-(2,2-bis((E)-octadec-9-en-1-yloxy)ethoxy)-N,N-dimethylethanamine 9b.

Sodium hydride

(60% in mineral oil, 2.68 g, 0.11 mol) was carefully mixed with hexanes (100 mL,
deoxygenated) under N2 at room temperature to separate NaH from mineral oil. After NaH
settled, hexanes were removed via syringe and isopropanol was used to quench any NaH
remaining in the removed hexanes solution and syringe. Anhydrous THF (20 mL) was added to
the NaH and the resulting solution mixture was cooled to 0°C. A solution of 2-(dimethylamino)
ethanol (1.87 mL, 0.019 mol) was added dropwise to the NaH solution. The resulting solution
was stirred at 0°C under N2 for 30 minutes. Then the solution was warmed to room temperature
and heated to reflux (68.8°C). A solution of 9a (4.0 g, 0.0062 mol) in anhydrous THF (150 mL)
was then added dropwise over a period of 30 minutes. The resulting reaction mixture stirred at
reflux (68.8°C) for 4 days. The reaction mixture was slowly cooled to room temperature and
subsequently cooled to 0°C. Then, water was added dropwise to quench any remaining NaH,
until gas evolution ceased. The reaction mixture was extracted with hexanes, washed with brine
and concentrated under reduced pressure producing a brown oil. In some cases, the crude
material was recrystallized from ethyl acetate and ethanol. Final purification was carried out via
column chromatography (silica gel, 20% CH3CN/CHCl3, 5% MeOH/CHCl3 – 15%
MeOH/CHCl3) affording a brown oil (1.43 g, 36%). 1H NMR (400 MHz, CDCl3) δ 5.46 – 5.26
(m, 4H), 4.61 (t, J = 5.2 Hz, 1H), 3.61 (dt, J = 8.9, 6.2 Hz, 4H), 3.57 – 3.40 (m, 4H), 2.55 (t, J =
5.6 Hz, 2H), 2.31 (s, 6H), 1.99 (dd, J = 13.4, 6.8 Hz, 8H), 1.56 (dd, J = 13.9, 6.8 Hz, 4H), 1.27
(d, J = 8.3 Hz, 44H), 0.88 (t, J = 6.7 Hz, 6H).

13

C NMR (300 MHz, CDCl3) δ 130.05, 101.08,

71.30, 69.00, 66.65, 58.31, 45.37, 32.34, 31.63, 29.74 , 28.60, 26.93, 25.89, 22.42, 13.86. MS
(ESI, high-resolution) ([M+1]+): 650.6887, calcd for [C42H83NO3]+ m/z: 650.64.
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N-(2-(2,2-bis((Z)-octadec-9-en-1-yloxy)ethoxy)ethyl)-2-ethoxy-N,N-dimethyl-2oxoethanaminium 9c.

To a solution of 9b (250 mg, 0.384 mmol) in THF (25 mL)

ethylbromoacetate (0.128 mL, 1.15 mmol) was added. The resulting reaction mixture was
stirred under reflux (68.8°C) for 3 days. The reaction mixture was cooled to room temperature
and solvent was removed under reduced pressure.
recrystallization from ethanol/ethyl acetate.

Minor product removed as a solid via

The filtrate was concentrated under reduced

pressure producing sticky brown oil. The oil was washed with a small amount of diethyl ether to
remove any excess ethyl bromoacetate to give 217 mg (0.294 mmol, 77%) of 9c. 1H NMR (400
MHz, CDCl3) δ 5.36 (d, J = 14.1 Hz, 4H), 4.87 – 4.37 (m, 5H), 3.77 – 3.35 (m, 16H), 2.20 (m,
8H), 1.89 – 1.03 (m, 51H), 0.95 – 0.51 (m, 6H).

13

C NMR (300 MHz, CDCl3) δ 156.80, 130.05,

101.08, 69.00, 67.52, 65.87, 62.76, 60.42, 50.87, 49.20, 33.95, 31.92, 29.74, 28.60, 26.93, 25.89,
22.42, 15.39, 13.86. MALDI-TOF/MS ([M]): 736.9, calcd for [C46H90NO5]+ m/z: 736.68.

2-((2-(2,2-bis((Z)-octadec-9-en-1-yloxy)ethoxy)ethyl)dimethyl ammonio)acetate 9.

To a

solution of 9c (210 mg, 0.285 mmol) in MeOH:THF:Brine (1:1:1) was added KOH (0.096 g) at
room temperature. The reaction mixture was sonicated for 30 minutes, filtered and concentrated
under diminished pressure affording a beige colored oil (165 mg, 0.233 mmol, 82%). 1H NMR
(300 MHz, CDCl3) δ 5.15 (ddt, J = 42.0, 12.2, 6.1 Hz, 4H), 4.92 – 4.75 (m, 2H), 4.63 (d, J = 36.1
Hz, 1H), 4.37 – 3.43 (m, 18H), 3.07 – 1.89 (m, 4H), 2.84 – 1.89 (m, 4H), 2.21 – 1.64 (m, 4H),
1.76 – 1.32 (m, 12H), 1.44 – 1.32 (m, 6H), 1.44 – 0.25 (m, 29H), 0.89 (t, J = 6.7 Hz, 6H).
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C

NMR (300 MHz, CDCl3) δ 156.80, 130.05, 101.08, 63.11, 50.90, 49.20, 33.97, 31.91, 29.74,
28.60, 26.93, 25.89, 22.42, 15.39, 13.86.

MALDI-TOF/MS ([M+H]): 708.9, calcd for

[C44H86NO5]+ m/z: 708.65.
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Triphenoxyacetamide 10 was synthesized according to the literature procedure.262
Cyclen tetraurea 1 was synthesized as described.237
4.3.3 Liposome Preparation for pH-Controlled Release Studies
Egg yolk L-α-phosphatidylcholine (EYPC, ethanol solution, 27 µL, 6.58 µmol), 1,2dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE, ethanol solution, 500 µL, 6.72 µmol), and
lipid 8 or lipid 9 (solution in CHCl3/MeOH/EtOH, 435 µL, 14.1 µmol) were combined and
dissolved in CHCl3 (5 mL), MeOH (0.5 mL) and EtOH (0.5 mL), then concentrated under
reduced pressure in the round-bottom flask to produce a transparent film (25 % EYPC, 25%
DOPE, 50% lipid 8 or lipid 9). The film was dried under high vacuum for 4 hours, and was
subsequently hydrated for 1 h in 800 µL of HPTS sodium phosphate buffer (100 µM HPTS, 100
mM NaCl or 75 mM Na2SO4, 10 mM sodium phosphate, pH 7.0). During the hydration process
the suspension was exposed to 10 freeze-thaw cycles (MeOH/dry ice, 45°C water bath). The
resulting suspension was submitted to 21 high-pressure extrusions at room temperature through a
0.1 µm membrane affording liposomes.

The liposomes were purified via size-exclusion

chromatography (Sephadex G-75 was used as a solid phase, the same buffer as used for the
hydration of liposomes except HPTS, was used as an eluent). The liposomes eluted as a cloudy
solution that appeared light blue under UV light (2.0 mL). For the incubation and fluorimetric
experiments, the collected liposomes were diluted in sodium phosphate buffer (100 mM NaCl,
10 mM sodium phosphate, pH 4-7.0) to a final concentration of 500 µM.
4.3.4 Fluorescence Studies of pH-Controlled Release of Liposome Contents
In a typical experiment, the suspension of liposomes (10.0 mL at 500 µM concentration
of total lipid) in sodium phosphate buffer (100 mM NaCl, 0-10 μM triphenoxyacetamide 10, 10
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mM sodium phosphate, pH 4-7.0) was stirred at room temperature. Aliquots of 2.0 mL were
analyzed at timepoints of initial, one hour, four hours, 11 hours and 24 hours. All flourometric
experiments at each timepoint were kept consistent. The 2.0 mL sample was loaded in a
thermostated spectrophotometric cell. The liposome suspension was stirred at 25°C during the
course of analysis. The emission of HPTS at 511 nm was monitored with concurrent excitation
at 405 and 460 nm. The emission and excitation slits of the spectrophotometer were set at 5 nm,
time increments were set at 2.0 s, and integration time was set at 0.5 s. The total time of each
experiment was 600 s. An injection of cyclen tetraurea 1 (20 μL of 1.0 mM solution in DMSO)
was made at 60 s, followed by the injection of Triton X-100 (40 μL of 25% wt/v in Millipore
H2O) at 500 s.
4.3.5 Liposome Preparation for Dynamic Light Scattering Studies
The preparations of liposomes were similar to those for pH-controlled release studies.
For these preparations the use of HPTS dye was omitted and liposomes were not passed through
a Sephadex column. The liposome suspension was transferred from an extruder syringe into a
vial, after 21 extrusions. The liposomes were diluted in sodium phosphate buffer (100 mM
NaCl, 10 mM sodium phosphate, pH 7.0) to a final conetration of 500 µM in the total lipid.
4.3.6 Dynamic Light Scattering Studies
Liposome suspensions (2.0 mL) were analyzed in a disposable cuvette at 25°C on a
Malvern Zetasizer Nano Series Instrument. An initial run was performed to determine the size of
the liposomes.

Then human serum albumin (HSA, 100 mg) was added to the liposome

suspension and the resulting suspension was mixed by inverting. All DLS runs consisted of 10
separate measurements of Z average obtained every four minutes, with the average value being
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reported for each experiment.
4.3.7 MTS Cell Proliferation Assay
B16F10 tumor cells were employed to evaluate liposomes for effects on cell viability
with the MTS [(3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxy-phenyl)-2-(4-sulfophenyl)2H-tetrazolium] assay. The MTS assay is a colorimetric method for determining the number of
viable cells by measuring the activity of enzymes that reduce MTS in the presence of phenazine
methosulfate to formazan, giving a purple color. After the cells (104 cells/well) were cultured in a
96-well plate for 3 days in the presence of various concentrations of small unilamellar vesicles
(SUVs), MTS solution (Promega) was added and the absorbance at 490 nm was recorded using a
96-well plate reader (Molecular Devices Thermomax Plate Reader, Rockville, MD). Results are
presented as the mean ± S.E. The student t-test was used for detection of differences.
Transmission images of the cells were obtained on Olympus IX50 microscope (Olympus Inc.,
Tokyo, Japan), using 20x magnification.
4.4 Results and Discussion
4.4.1 Formulation of Liposomes
In order to develop an operational drug delivery system, an appropriate lipid composition
for the formulation of the liposomes had to be determined. The proper liposomal composition
would allow us to accomplish the following: 1) to encapsulate the drug model in liposomes and
2) to release this model upon hydrolysis of acetal groups of lipids 8 or 9. 8-Hydroxypyrene1,3,6-trisulfonic acid (HPTS) was chosen as the drug model.266

When encapsulated in

liposomes, this pH sensitive dye can detect internal pH changes through the change in
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fluorescence of its protonated and deprotonated forms; furthermore, the release of the dye can be
monitored through exogenous application of cyclen-tetrathiourea compound 1.237

This

membrane-impermeable compound binds to HPTS dye in PBS with submicromolar affinity and
high selectivity, and quenches 90% of its fluorescence.237

The typical calcein and

carboxyfluorescein release assays267, 268 cannot be used for these purposes, as a consequence of
the high (100 mM) concentration of dye required for the fluorescence self-quenching. At these
concentrations, the dyes with pKa’s of 6.7-7.0269 would act as buffering compounds and preclude
acidification of liposomal interior during the uptake of HCl. At the same time, liposomes, loaded
with HPTS dye at low (100 μM) concentration can be readily acidified through co-transport of
HCl. A different technique for monitoring of contents release, that relies on the encapsulated
mixtures of HPTS and p-xylene-bis-pyridinium bromide (DPX)256,

270, 271

was also proven

unsuitable for our purposes. In this technique, for optimal quenching of the HPTS fluorescence,
DPX has to be used at 50 mM concentration, which creates 100 mM internal concentration of
bromide anion. Bromide is also a substrate for the HCl co-transporter 10 (unpublished data);
therefore, the efflux of HBr from liposomes would nullify the effects produced by the influx of
HCl.
The proper lipid composition was determined by monitoring of the extent of HPTS
encapsulation. In a typical experiment, a 2 mL aliquot of the stock suspension of liposomes (see
experimental) was transferred into a fluorimetric cell, and 10 μL of 1 mM solution of compound
cyclen 1 in DMSO was injected, followed by the injection of the detergent Triton X-100. The
extent of fluorescence quench upon injection of compound cyclen 1 was attributed to the portion
of the dye remaining outside the liposomes. The extent of fluorescence quenching after the lysis
of liposomes with Triton X-100 was due to the dye encapsulated in the aqueous compartments of
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liposomes and therefore not accessible to compound cyclen 1 prior to lysis. We found that
neither lipid 8, nor lipid 9 were capable of encapsulating HPTS dye when utilized in their pure
forms. Presumably, the two lipids did not form liposomes at all; consequently, a more complex
mixture of lipids was used as an alternative.
We found that the most effective encapsulation of HPTS dye occurred for the lipid
formulations comprising 25 mol% of EYPC, 25 mol% of DOPE and 50% of lipid 8 or 9.
4.4.2 pH-Dependent Release of Contents
First, we demonstrated that liposomes containing lipids 8 and 9 were actually pH
sensitive. To accomplish this, two sets of liposomes formulated with lipid 8 and lipid 9, were
prepared in PBS (100 mM NaCl, 10 mM Pi, pH = 7.0, 100 μM HPTS inside). Then, these
liposomes were incubated in HPTS-free PBS at pH 4 and 6, respectively, for various periods of
time, as detailed in the experimental section. After incubation, liposomes were transferred into a
fluorimetric cell, and the fluorescence of HPTS was monitored (ex 405 nm, em 510 nm). During
each experiment, a DMSO solution of compound cyclen 1 was injected, followed by lysis of
liposomes with Triton X-100 at 500 s.
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Liposomes prepared from lipid 9 were stable at neutral pH for only about 1 hour and
displayed an instant collapse at reduced pH. However, liposomes prepared from lipid 8 were
stable at neutral pH for extensive periods of time and showed pH-dependent contents release at
lower pH (Figure 4.1A). Thus, at pH 6, liposomes formulated with lipid 8 did not exhibit a
significant release of HPTS for the first 24 hours, yet, a rapid release of HPTS from these
liposomes was observed in the next 12 hours (Figure 4.1B).

The same liposomes, when

incubated in PBS at pH 4, were stable for 4 hours, and released their entire contents after 8 hours
of incubation. These experiments demonstrated that liposomes prepared from lipid 8 were
indeed pH sensitive. A rather quick then gradual release of the dye is consistent with rapid
liposome to micelle transition, caused by a buildup of amphiphilic hexadecanol in the membrane
of liposomes upon hydrolysis of lipid 8.272, 273
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Figure 4.1: Release of HPTS Dye from Liposomes Prepared from 25 mol% EYPC,
25 mol% DOPE and 50 % Lipid 8, Monitored by Quenching (ex 405 nm, em 510
nm) of HPTS Fluorescence by 10 μM Exogenous Cyclen 1: (A) External pH is set at
4.0. Traces from top to bottom denote: 1) 0 hours of incubation; 2) 4 hours of
incubation; 3) 8 hours of incubation. (B) External pH is set at 6.0. Traces from top to
bottom denote: 1) 0 hours of incubation; 2) 12 hours of incubation; 3) 24 hours of
incubation; 4) 36 hours of incubation. Time events in the course of experiments: 60
sec – cyclen 1 was added; 500 sec – 0.5% Triton X-100.
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4.4.3 Release of HPTS from Asymmetric Liposomes
After revealing that formulations of liposomes containing lipid 8, respond to the external
change in pH, we demonstrated that the variations in internal pH could also affect their stability.
In order to achieve this task, two populations of liposomes were prepared with an identical lipid
composition (25 mol% DOPE, 25 mol% EYPC and 50 mol% lipid 8) but various aqueous
internal contents. The first set was formulated with PBS (100 mM NaCl, 10 mM P i, pH = 7, 100
μM HPTS), and the second set of liposomes was formulated with sodium sulfate instead of
sodium chloride (75 mM Na2SO4, 10 mM Pi, pH = 7, 100 μM HPTS). Seventy-five mM Na2SO4
was used in place of 100 mM NaCl to ensure isoosmolality of the internal solution of liposomes
to that of the external PBS.274
Both populations of liposomes were suspended in PBS followed by the subsequent
addition of 10 μM compound 10.

Liposomes containing Na2SO4 demonstrated rapid

acidification of their internal compartments to a pH of approximately 5.6, as evidenced by
change in the fluorescence of HPTS (Figure 4.2A, lower trace).266 After acidification, the
internal pH did not change significantly until liposomes were lysed with Triton X-100, after a
period of 1 hour. A small increase in the internal pH (~ 0.1 pH units) observed during this time
was most likely due to insignificant decomposition of liposomes and subsequent release of the
dye. Lysis of liposomes resulted in a complete release of HPTS into the external buffer, which
caused the increase of pH back to 7. Application of compound 10 to the suspension of NaClcontaining liposomes did not produce a change in the internal pH due to the lack of Cl - gradient
across the bilayer membrane (Figure 4.2A, upper trace).
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Figure 4.2: pH Relationships for Triphenoxyacetamide 10 and HPTS Dye: (A)
Change in the internal pH of liposomes upon application of triphenoxyacetamide 10.
Upper trace at 2000 s corresponds to symmetrical liposomes (100 mM NaCl, 10 mM
Pi inside and outside). Lower trace corresponds to asymmetrical liposomes (75 mM
Na2S04, 10 mM Pi inside, 100 mM NaCl, 10 Pi outside). The pH was monitored as a
function of Irel, where Irel = I460/I405. Time events: 60 s – 10 μM triphenoxyacetamide
10 added, 3660 s – 0.5% liposomes lysed with 0.5% Triton X-100. (B) Calibration
plot relating Irel of HPTS to the actual pH of the solution. Inset shows linear fit
equation for the low pH (pH < 6.5) and quadratic fit equation for the high pH (pH >
6.5).
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Figure 4.3: Contents Release from Symmetrical (NaClin/out) and Asymmetrical
(Na2SO4in/NaClout) Liposomes, Formulated with Lipid 8: (A) Fluorimetric kinetic
experiments for contents release from symmetrical liposomes. HPTS emission (ex =
405, em = 510) was monitored as function of time. Prior to the experiments,
liposomes were incubated in PBS with 10 μM compound 10 for various periods of
time as denoted in the inset. (B) The same experiments with asymmetrical liposomes.
Time events: 60 s: 10 μM compound cyclen 1; 500 s: 0.5% Triton X-100.
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After verifying that liposomes that are under a Cl- gradient can be acidified by application
of triphenoxyacetamide 10, we incubated both populations of liposomes in PBS for various
periods of time.

At the end of each period, the extent of contents release was analyzed

fluorimetrically (Figure 4.3). The symmetrical liposomes (NaClin/out) did not show substantial
release of the dye for at least four days, but liberated all their contents after 6.5 days. At the
same time, asymmetrical liposomes (Na2SO4in/NaClout) were stable for only 13 hours, and
released their contents almost completely after 2.5 days.
Finally, we decided to prepare a mixture of both populations of liposomes and
consequently analyze the contents release using this model (Figure 4.4). As can be seen, the
release of contents illustrated an intricate profile, wherein the periods of inactivity were followed
by rather rapid release of HPTS. A plateau at ~96 hours of incubation corresponds to the time
segment, where the entire contents of the asymmetrical subpopulation of liposomes was released,
and the symmetrical liposomes did not begin to decompose yet. This observation suggests that
for the preferred concentration of liposomal suspension, there was no transfer of hexadecanol
from the micelles into the intact liposomes, and no hexanol-induced fusion of the hydrolyzed and
intact membranes took place; two populations of liposomes released their contents independently
from each other. This observation is similar to that reported for the oleoyl alcohol effects on the
stability of pH-sensitive liposomes.275

Although the initial period of inactivity for the

aforementioned mixture of liposomes was approximately 12 hours, a faster release of the
contents could be achieved through addition of a more flexible and hence more pH-sensitive
lipid 9 into the formulation of liposomes.
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Figure 4.4: Contents Release from the 1:1 Mixture of Two Sets of Liposomes,
Formulated with Lipid 8: Set 1: 100 mM NaCl inside, 10 mM Pi, pH = 7, 100 μM
HPTS. Set 2: 75 mM Na2SO4 inside, 10 mM Pi, pH = 7, 100 μM HPTS. Both sets
were incubated in the HPTS-free PBS (100 mM NaCl, 10 mM Pi, pH = 7, 10 μM
triphenoxyacetamide 10). (A) Fluorimetric kinetic experiments for contents release.
From top to bottom at 300 s traces denote the following incubation times: 0, 6, 12, 18,
24, 30, 42, 48, 60, 72, 84, 96, 120 and 168 hours, respectively. Time events: 60 s: 10
μM compound cyclen 1; 500 s: 0.5% Triton X-100. (B) Percentage of contents release
from the kinetic experiments, as a function of incubation times.
4.4.4 Biocompatibility
Although this work did not involve any in vivo studies, the principal biocompatibility of
these pH-sensitive liposomes was demonstrated. It is known that liposomes with a net positive
charge on their surface are rapidly cross-linked with serum albumin within blood plasma and
then cleared from circulation.276,

277

Dynamic light scattering (DLS) studies can be used for

monitoring of the relative size of particles in the presence of human serum albumin (HSA). 90, 278,
279

We performed a series of DLS experiments on four types of liposomes. Two sets were

formulated using lipids 8 and 9, and two other sets were formulated with cationic precursors 8c
and 9c. The latter formulations were used as positive controls, since they were expected to
change in size upon interactions with HSA.
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In the absence of HSA all four formulations of liposomes were approximately 100 nm in
diameter (Figure 4.5A), consistent with the extrusion of liposomes through 100 nm pores.
However, incubation of these liposomes with HSA for 40 minutes resulted in a formation of
particles of varying sizes in all four experiments. Small size particles of about 6 nm were
observed immediately upon addition of HSA, which is consistent with the size of human serum
albumin globules.280 Larger size particles with the diameter of 300-1000 nm were detected
immediately upon addition of HSA to the suspensions of liposomes formulated with cationic
lipids 8c and 9c (Figure 4.5B, two bottom traces). No such immediate formation of larger
particles was observed during the first 20 minutes for lipids 8 and 9. However, a small amount
of larger aggregates with the diameter of ~ 800 nm became detectable for lipid 9 after 40 minutes
(Figure 2B, third trace from the bottom).

Formulation with lipid 8 did not undergo any

noticeable changes during this time (Figure 4.5B, upper trace). These results suggest that at
least liposomes formulated with lipid 8 do not form large aggregates in the presence of HSA, and
therefore potentially suitable for the in vivo applications.
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Figure 4.5: Dynamic Light Scattering Experiments on the Liposomes Formulated with
Lipids 8 or 9 and their Cationic Precursors 8c and 9c in the Absence (stack A) and in the
Presence (stack B) of Human Serum Albumin: In both stacks, traces from top to bottom
denote liposomes formulated with lipids: 1) 8; 2) 9; 3) 8c; 4) 9c.
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4.4.5 Cytotoxicity of Liposomal Formulations
To show general non-toxicity of liposomal formulations, we conducted cell viability
assays with liposomes, formulated with lipid 8 and compound 10. Since compound 10 is a HCl
co-transporter, it was possible that this compound exhibits certain cytotoxicity as other natural
HCl co-transporters (e.g.,

prodigiosin).281,

282

However, when B16F10 tumor cells were

incubated with the synthetic liposome mixture, at concentrations exceeding 1 mM (total lipid
concentration) and compound 10 at 20 μM concentration, cell proliferation was indistinguishable
from the negative control (Figure 4.6A). In contrast, the positive control experiment, in which
the cells were incubated with a potent cytotoxin curcumin,283, 284 resulted in virtually complete
cell death, signifying that the cell culture responded to the cytotoxic substances.

No

morphological signs of cell change or death were observed upon treatment of B16F10 tumor
cells with the aforementioned liposomes (Figure 4.6B).285
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Figure 4.6: Viability Studies of B16F10 Tumor Cells: (A) Liposomes with lipid 8 had no
effect on the viability of B16F10 tumor cells. B16F10 tumor cell viability in the presence
of various concentrations of liposomes or 10 g/mL curcumin (positive control, PC, for
72 hours. The sign “**” indicates p  0.01 determined by the Student t-test. (B) Cell
images in the absence (panel a) and in the presence of liposomes with lipid 8 and HCl cotransporter 10 (panels b and c correspond to the total lipid concentration of 0.58 mM and
1.16 mM, respectively). Cell image upon treatment with curcumin (panel d).
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4.5 Conclusions
In conclusion, we developed a new controlled drug release system that is based on a
mixture of several populations of pH-sensitive liposomes. Unlike other pH-responsive drug
delivery systems that required exogenous acidification for release, this system was initiated
through the acidification of the internal aqueous compartments of liposomes upon the contact
with physiologically relevant solution of NaCl. A degree of such acidification was controlled by
the internal concentrations of NaCl and allowed to release the contents of liposomes in 12 hours
through 7 days. The drug delivery system, based on lipid 8 was shown to be not sensitive to the
physiological concentrations of HSA, and non-toxic at total lipid concentrations of up to 1 mM
and concentrations of compound 10 up to 20 μM. Our future studies will focus on extension of
the time range for the controlled drug release, as well as on the in vivo applicability of this new
drug delivery system.
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Chapter 5
Conclusions and Future Work

5.1 Summary of this Work
This work focuses on the development of cyclen-thiourea based receptors which have a
high affinity for fluorescent dyes. Specifically, our research group designed and synthesized a
receptor we named cyclen 1 which has a high affinity for pyrene-based dyes. These receptorfluorescent dye pairs provide a non-invasive, physiologically compatible, accurate methodology
suitable for the study of biomembrane leakage and lipid flip events, which are both critical
processes in cellular membrane activity. The approaches described within this work address
intrinsic deficiencies that have been observed in widely accepted protocols. These undesirable
interactions with the bilayer membranes have arisen from the small nature of the molecular probe
compounds utilized in these protocols. This newly proposed macromolecular approach enables
the fluorometric detection of biomembrane events, which are in high demand by the biochemical
community and a target for developmental pharmaceuticals. These receptor-dye complexes
provide useful insight into biomembrane processes including molecular transport which is
monitored by our novel membrane leakage assay as well as lipid translocation utilizing the lipid
flip assay. Our research group has also formulated and developed a newly-designed drug
delivery system which can be monitored using the cyclen 1–pyranine membrane leakage assay.
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Overall, this new macromolecular receptor-dye complexation has great potential for application
in multiple fields including chemistry, biochemistry, pharmacology and cell biology.
5.2 Future Directions
5.2.1 Further Development and Application of the Membrane Leakage Assay
Design of additional cyclen-based receptors.
The design and synthesis of the receptor cyclen 1, which has a high affinity to pyranine
dye under near-physiological conditions and is impermeable to the bilayer membrane, has led to
a novel membrane leakage assay that is fully compatible with the pH-stat assay. This assay
enables the distinction between ion transport and membrane leakage within a single set of
experiments. Although the newly designed receptor-dye complexes present advancements over
currently utilized membrane leakage assays, there are some limitations in the applicability of
cyclen 1 to biomembrane assays. These limitations primarily arise from its quenching efficiency
and low solubility in aqueous medium. Hence, it would be advantageous to pursue the synthesis
of a new receptor with a higher quenching affinity. A higher quenching efficiency for the
receptor-dye complex could potentially lead to lower operating concentrations of dye, thus
enabling a more physiologically compatible study. Therefore, future studies will focus on the
development and synthesis of new cyclen-based
receptors.

Specifically, it has been shown that p-

xylene-bis-pyridinium bromide (Figure 5.1, DPX) can
quench almost 100% of HPTS fluorescence.25

We

hypothesize that the inclusion of the charged DPX
moiety could possibly increase the solubility of the
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Figure 5.1: Structure of DPX

receptor in aqueous medium, while potentially improving the quenching efficiency of the
receptor. Therefore, in order to improve these characteristics, a new cyclen-based derivative
which incorporates DPX will be synthesized. Once this compound has been synthesized it will
be characterized and applied to the membrane leakage assay. Within this study, we have also
shown some limited applicability of cyclen 1-pyranine complexation to the detection of
endovesiculation, and we are therefore also hopeful that an improved DPX fluorescence
quencher will also be compatible with the endovesiculation assay.
Assessment of pore sizes through the new membrane leakage assay.
The currently developed membrane-leakage assay provides a possibility to distinguish
between selective ionophores and large pores. We believe that the same assay can be utilized to
assess the size of the pore by measuring the kinetics of HPTS leakage.

At micromolar

concentration, the leakage rate of HPTS is determined by free diffusion through the pores. The
pore size comparable with the diameter of HPTS (~ 8 Å) should limit this diffusion rate due to
the steric hindrance (Scheme 5.1). The rate constants for HPTS leakage will be plotted as a
function of pore size, allowing the leakage rate constant to be used to calculate the pore size
formed by compounds with unknown characteristics. This assay is limited by the size of HPTS
molecule, meaning, any pore smaller than the HPTS will be inaccessible. We will expand the
limits of the pore size assessment by employing experiments with dyes of smaller size (ANTS, ~
5 Å for example). For calibration, the membrane leakage experiments will be performed with
LUVs loaded with HPTS in the presence of the pore-forming peptides magainin,286
alamethicin,287 and hemolysin,288 whose pore characteristics are well-established. The sizes of
the pores in the presence of LUVs formulated with ceramides can be incrementally adjusted by
varying the ceramide concentrations relative to the other lipid ratios within the LUVs.289 If this
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method turns out to be valid, the pore size assessment assay will become a valuable tool to the
biochemical community, as there is no such assay generally adopted for the spherical bilayers.290
(An assay described in literature operates with LUVs containing high calcein at high
concentration. Due to these reasons, this assay is not really useful for pore size assessment.)
Additionally, electrophysiological pore size assessments utilize the membrane model under
different conditions.291
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Scheme 5.1: Proposed calibration study for assessment of pore sizes. HPTS
leakage rate constants will be plotted as function of pore size formed from
known pore-forming compounds.
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5.2.2 Further Development and Application of the Lipid Flip Monitoring Assay
In the second part of this work, the receptor-pyranine complexation185 was applied to the
development of a new methodology for monitoring of lipid flip in both model and cell
membranes.

This methodology relies on the micromolar concentrations of the previously

synthesized fluorescence quencher cyclen 1 and has demonstrated potential for reversible
quenching with a newly synthesized cascade-blue labeled lipid.186 Therefore, we show that the
new methodology has better compatibility with the physiological conditions than the commonly
utilized NBD-dithionite methodology, that relies on high millimolar concentrations of sodium
dithionite and the irreversible quenching of the fluorescence of NBD-labeled lipid by
dithionite.168,

169, 292

Furthermore, wild type human P-glycoprotein, (Pgp), which is a known

flippase,171 facilitates lipid flip to a lesser extent then Pgp treated with the reducing agents,172
whereas the activity of human scramblase protein is suppressed by reducing reagents.173 These
examples demonstrate that dithionite may affect the flipping activity of enzymes in a dual way
and, therefore, cannot be used in the real time monitoring experiments. Hence, the focus of our
future studies will be a real-time monitoring of the flippase activity of Pgp, using the newly
developed lipid flip monitoring assay. Lastly, since we were able to utilize the fluorescently
labeled lipids for the in vitro studies, the synthesis of a variety of lipids with differing
hydrophobicities could provide lipids with differing time-intervals of lipid flip. This variation
could be beneficial in the real-time monitoring of flippases, floppases and scramblases.
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5.2.3 Further Development and Application of the pH-Sensitive Controlled Drug Release
System
In the last part of this work a new controlled drug release system was developed. This
system is based on a mixture of several populations of pH-sensitive liposomes containing NaCl
that lyse upon internal acidification. The degree of acidification was controlled by the internal
concentrations of NaCl which allowed the release of the contents of liposomes, from 12 hours
through 7 days, upon the application of exogenous HCl co-transporter 10. The drug delivery
system, based on lipid 8 was shown to be not sensitive to the physiological concentrations of
HSA, and non-toxic at total lipid concentrations of up to 1 mM and concentrations of compound
10 up to 20 μM. Our future studies will focus on extension of the time range for the controlled
drug release. To begin, this will be accomplished through the syntheses of a wide range of
additional hydrolysable lipids. Additionally, we will also focus on the in vivo applicability of
this new drug delivery system.
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Figure B1: 1H NMR of Lipid 5 in CDCl3
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Figure B2: 1H NMR of Lipid 7(i) in CDCl3
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Figure B3: 1H NMR of Lipid 7(ii) in CDCl3
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